US20120245600A1 - Anchor delivery system with replaceable cartridge - Google Patents

Anchor delivery system with replaceable cartridge Download PDF

Info

Publication number
US20120245600A1
US20120245600A1 US13/489,793 US201213489793A US2012245600A1 US 20120245600 A1 US20120245600 A1 US 20120245600A1 US 201213489793 A US201213489793 A US 201213489793A US 2012245600 A1 US2012245600 A1 US 2012245600A1
Authority
US
United States
Prior art keywords
assembly
needle
anchor
delivery device
actuator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/489,793
Inventor
Matthew McLean
Mitchell C. Barham
Michael Wei
Floria Cheng
Andrew L. Johnston
Michael Gearhart
Joseph Catanese, III
Theodore C. Lamson
Joshua Makower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teleflex Life Sciences Ltd
Original Assignee
Neotract Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/134,870 external-priority patent/US7758594B2/en
Priority claimed from US11/318,246 external-priority patent/US7645286B2/en
Priority claimed from US11/492,690 external-priority patent/US7896891B2/en
Priority claimed from US11/671,914 external-priority patent/US8157815B2/en
Priority claimed from US11/775,162 external-priority patent/US8945152B2/en
Priority to US13/489,793 priority Critical patent/US20120245600A1/en
Application filed by Neotract Inc filed Critical Neotract Inc
Publication of US20120245600A1 publication Critical patent/US20120245600A1/en
Assigned to Neotract, Inc reassignment Neotract, Inc ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MAKOWER, JOSHUA, CATANESE, JOSEPH, III, LAMSON, THEODORE C, WEI, MICHAEL, BARHAM, MITCHELL, CHENG, FLORIA, GEARHART, MICHAEL, JOHNSTON, ANDREW L, MCLEAN, MATTHEW
Assigned to CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., CAPITAL ROYALTY PARTNERS II L.P., PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P. reassignment CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P. SHORT-FORM PATENT SECURITY AGREEMENT Assignors: NEOTRACT, INC.
Assigned to NEOTRACT, INC. reassignment NEOTRACT, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., CAPITAL ROYALTY PARTNERS II L.P., PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Assigned to TELEFLEX LIFE SCIENCES LIMITED reassignment TELEFLEX LIFE SCIENCES LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEOTRACT, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3468Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3478Endoscopic needles, e.g. for infusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00274Prostate operation, e.g. prostatectomy, turp, bhp treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/0046Surgical instruments, devices or methods, e.g. tourniquets with a releasable handle; with handle and operating part separable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00792Plastic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00796Breast surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00805Treatment of female stress urinary incontinence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0409Instruments for applying suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417T-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0419H-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0464Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0479Packages or dispensers for MIS suturing instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0487Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
    • A61B2017/0488Instruments for applying suture clamps, clips or locks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B2017/06052Needle-suture combinations in which a suture is extending inside a hollow tubular needle, e.g. over the entire length of the needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B2017/06095Needles, e.g. needle tip configurations pliable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/28Surgical forceps
    • A61B17/29Forceps for use in minimally invasive surgery
    • A61B17/2909Handles
    • A61B2017/2912Handles transmission of forces to actuating rod or piston
    • A61B2017/2923Toothed members, e.g. rack and pinion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00547Prostate

Definitions

  • the present invention relates generally to medical devices and methods, and more particularly to systems and associated methods for manipulating or retracting tissues and anatomical or other structures within the body of human or animal subjects for the purpose of treating diseases or disorders and/or for cosmetic or reconstructive or other purposes.
  • Such procedures are often carried out for the purpose of treating or palliating the effects of diseases or disorders (e.g., hyperplasic conditions, hypertrophic conditions, neoplasias, prolapses, herniations, stenoses, constrictions, compressions, transpositions, congenital malformations, etc.) and/or for cosmetic purposes (e.g., face lifts, breast lifts, brow lifts, etc.) and/or for research and development purposes (e.g., to create animal models that mimic various pathological conditions).
  • diseases or disorders e.g., hyperplasic conditions, hypertrophic conditions, neoplasias, prolapses, herniations, stenoses, constrictions, compressions, transpositions, congenital malformations, etc.
  • cosmetic purposes e.g., face lifts, breast lifts, brow lifts, etc.
  • research and development purposes e.g., to create animal models that mimic various pathological conditions.
  • BPH Benign Prostatic Hyperplasia
  • the prostate gland enlarges throughout a man's life.
  • the prostatic capsule around the prostate gland may prevent the prostate gland from enlarging further. This causes the inner region of the prostate gland to squeeze the urethra. This pressure on the urethra increases resistance to urine flow through the region of the urethra enclosed by the prostate.
  • the urinary bladder has to exert more pressure to force urine through the increased resistance of the urethra.
  • Chronic over-exertion causes the muscular walls of the urinary bladder to remodel and become stiffer. This combination of increased urethral resistance to urine flow and stiffness and hypertrophy of urinary bladder walls leads to a variety of lower urinary tract symptoms (LUTS) that may severely reduce the patient's quality of life.
  • LUTS lower urinary tract symptoms
  • LUTS may also be present in patients with prostate cancer, prostate infections, and chronic use of certain medications (e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine etc.) that cause urinary retention especially in men with prostate enlargement.
  • certain medications e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine etc.
  • BPH is rarely life threatening, it can lead to numerous clinical conditions including urinary retention, renal insufficiency, recurrent urinary tract infection, incontinence, hematuria, and bladder stones.
  • Surgical procedures for treating BPH symptoms include Transurethal Resection of Prostate (TURP), Transurethral Electrovaporization of Prostate (TVP), Transurethral Incision of the Prostate (TUIP), Laser Prostatectomy and Open Prostatectomy.
  • TURP Transurethal Resection of Prostate
  • TVP Transurethral Electrovaporization of Prostate
  • TUIP Transurethral Incision of the Prostate
  • Laser Prostatectomy Open Prostatectomy.
  • Minimally invasive procedures for treating BPH symptoms include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
  • TUMT Transurethral Microwave Thermotherapy
  • TUNA Transurethral Needle Ablation
  • ILC Interstitial Laser Coagulation
  • Prostatic Stents include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
  • the most effective current methods of treating BPH carry a high risk of adverse effects. These methods and devices either require general or spinal anesthesia or have potential adverse effects that dictate that the procedures be performed in a surgical operating room, followed by a hospital stay for the patient.
  • the methods of treating BPH that carry a lower risk of adverse effects are also associated with a lower reduction in the symptom score. While several of these procedures can be conducted with local analgesia in an office setting, the patient does not experience immediate relief and in fact often experiences worse symptoms for weeks after the procedure until the body begins to heal. Additionally all device approaches require a urethral catheter placed in the bladder, in some cases for weeks.
  • catheterization is indicated because the therapy actually causes obstruction during a period of time post operatively, and in other cases it is indicated because of post-operative bleeding and potentially occlusive clot formation.
  • drug therapies are easy to administer, the results are suboptimal, take significant time to take effect, and often entail undesired side effects.
  • UI urinary incontinence
  • the severity of UI varies and, in severe cases, the disorder can be totally debilitating, keeping the patient largely homebound. It is usually associated with a cystocele, which results from sagging of the neck of the urinary bladder into or even outside the vagina
  • the treatments for UI include behavioral therapy, muscle strengthening exercises (e.g., Kegel exercises), drug therapy, electrical stimulation of the pelvic nerves, use of intravaginal devices and surgery.
  • an incision is typically made in the abdominal wall a few inches below the navel and a network of connectors are placed to support the bladder neck.
  • the connectors are anchored to the pubic bone and to other structures within the pelvis, essentially forming a cradle which supports the urinary bladder.
  • sling procedures In sling procedures, an incision is typically made in the wall of the vagina and a sling is crafted of either natural tissue or synthetic (man-made) material to support the bladder neck. Both ends of the sling may be attached to the pubic bone or tied in front of the abdomen just above the pubic bone. In some sling procedures a synthetic tape is used to form the sling and the ends of the synthetic tape are not tied but rather pulled up above the pubic bone.
  • these procedures are performed by creating incisions through the skin, dissecting to a plane beneath muscles and fascia, freeing the muscles, fascia and overlying skin from underlying structures (e.g., bone or other muscles), lifting or repositioning the freed muscles, fascia and overlying skin and then attaching the repositioned tissues to underlying or nearby structures (e.g., bone, periostium, other muscles) to hold the repositioned tissues in their new (e.g., lifted) position. In some cases excess skin may also be removed during the procedure.
  • underlying structures e.g., bone or other muscles
  • connector suspension lifts have been developed where one end of a standard or modified connector thread is attached to muscle and the other end is anchored to bone, periostium or another structure to lift and reposition the tissues as desired.
  • Some of these connector suspension techniques have been performed through cannulas or needles inserted though relatively small incisions of puncture wounds.
  • the present invention addresses these and other needs.
  • the present invention is directed towards an apparatus and method for deploying an anchor assembly within a patient's body.
  • the apparatus of the present invention includes various subassemblies which are mobilized via a trigger or other manually accessible structure. The operation of the subassemblies is coordinated and synchronized to ensure accurate and precise implantation of an anchor assembly. Structure for re-loading of the device is also described.
  • the delivery device is embodied in a tissue approximation assembly.
  • the tool includes a case assembly enclosing a trigger assembly, a needle spool assembly and a replaceable cartridge assembly. Extending from the case assembly and attached to the trigger assembly and needle spool assembly is a shaft assembly. Also, extending through the shaft assembly and connected to the trigger assembly are a pusher assembly, needle, and a cutter assembly. Operatively associated with the needle spool and cartridge assemblies are a needle actuator and a needle retraction actuator (e.g., a lever assembly). A rear actuator is operatively associated with the trigger assembly. This actuator can be positioned on a side of the instrument and can also be incorporated into the lever.
  • each of the actuators can be incorporated into a single structure for creating movement of internal mechanisms of the device.
  • Activation of the needle actuator accomplishes the advancement of a needle assembly and a first component of an anchor assembly attached to a connector member, to an interventional site.
  • Activation of the needle retraction actuator withdraws the needle assembly leaving the first component of the anchor assembly at the interventional site. Thereafter, manipulation of the rear actuator results in lockingly engaging a second anchor component with the connector member and cutting the connector member to a desired length.
  • the present invention is directed towards a delivery device which accomplishes the delivery of a first or distal anchor assembly component at a first location within a patient's body and the delivery of a second or proximal anchor assembly component at a second location within the patient.
  • the device also accomplishes imparting a tension during delivery and a tension between implanted anchor components as well as cutting the anchor assembly to a desired length and assembling the proximal anchor in situ.
  • the procedure can be viewed employing a scope inserted in the device.
  • the delivery device can be sized and shaped to be compatible with a sheath in the range of 18 to 24 F, preferably a 19 F sheath.
  • actuating a needle deploy actuator results in a needle assembly being advanced within a patient to an interventional site.
  • Activating a needle retraction lever accomplishes the withdrawal of the needle and deployment of a first anchor component of an anchor assembly at the interventional site.
  • Depression of a second actuator facilitates the incorporation of a second component into the anchor assembly and its release at the interventional site.
  • a reset assembly is further provided to reset aspects of the delivery system as is a bail out assembly configured to release anchor structure from the delivery device.
  • various locking mechanisms are provided for both operational as well as safety reasons.
  • the present invention also contemplates a reversible procedure as well as an anchor assembly with sufficient visibility when viewed ultrasonically, by xray, MRI or other imaging modalities.
  • the implant procedure is reversible by severing a connector of an anchor assembly and removing an anchor of the anchor assembly such as by removing a proximally placed anchor previously implanted in an urethra.
  • the anchor assemblies can be formed of structures such as that having increased density to thereby facilitate ultrasound viewing or other imaging modalities.
  • the anchor assembly can be configured to accomplish retracting, lifting, compressing, supporting or repositioning tissue within the body of a human or animal subject.
  • the apparatus configured to deploy the anchor assembly as well as the anchor assembly itself are configured to complement and cooperate with body anatomy.
  • the anchor assembly may be coated or imbedded with therapeutic or diagnostic substances, in particular Botulinum toxin, or a silver ion coating or such substances can be introduced into or near an interventional site by the anchor deployment device or other structure.
  • the anchor delivery device includes a handle assembly with a actuator attached thereto.
  • the actuator is associated with a body of the handle assembly and is operatively attached to the needle assembly and structure that advances the first anchor member.
  • a second actuator is operatively associated with structure that accomplishes assembling the second anchor member to the connector member.
  • the handle assembly is equipped with structure that is configured in one contemplated embodiment, to effect the cutting of the anchor assembly to a desired length and deployment of the structure at an interventional site.
  • the anchor delivery device includes a generally elongate tubular housing assembly member extending distally from a handle assembly including an actuator.
  • the proximal end of the handle assembly is equipped with mounting structure configured to receive a telescope or other endoscopic viewing instrument.
  • a bore sized to receive the telescope extends distally through a body of the handle assembly and continues through an outer tubular cover member forming the generally elongate member.
  • a telescope tube having an interior defining a distal section of the bore sized to receive the telescope, an upper tubular member assembly sized to receive at least one component of the implant assembly through a needle housing configured to receive the needle assembly, and a lower tubular member assembly sized to receive at least one second component of the implant assembly through a cutter member.
  • the first anchor member includes a tubular portion, a mid-section and a tail portion.
  • the tail portion of the member further includes a connector section which acts as a resilient member.
  • a terminal end portion of the tail is further contemplated to have a surface area larger than the connector section to provide a platform for engaging tissue.
  • one component of the second anchor member is embodied in a pin having a first end equipped with a pair of spaced arms and a second end defining a flattened tube.
  • the invention may be used to facilitate volitional or non-volitional flow of a body fluid through a body lumen, modify the size or shape of a body lumen or cavity, treat prostate enlargement, treat urinary incontinence, support or maintain positioning of a tissue, organ or graft, perform a cosmetic lifting or repositioning procedure, form anastomotic connections, and/or treat various other disorders where a natural or pathologic tissue or organ is pressing on or interfering with an adjacent anatomical structure.
  • the invention has a myriad of other potential surgical, therapeutic, cosmetic or reconstructive applications, such as where a tissue, organ, graft or other material requires retracting, lifting, repositioning, compression or support.
  • the disclosed device can have a compact shaft profile which, for example, can fit into a 19 F cystoscopic sheath for patient tolerant access during an awake procedure.
  • the device has a stiff distal shaft to allow manual compression of tissue at an interventional site by means of leveraging the tool handle.
  • a spring-driven needle can be deployed to a single depth, and sized to pierce through a predominate population of urethral-prostatic distances. An automated deployment of the needle through anatomy is contemplated to pierce reliably with sufficient force and speed.
  • the device can be provided with structure providing manual retraction of the needle to provide tactile feedback to the user to confirm completion of needle retraction. This also simplifies the mechanics to provide the option to retract the needle at any time and results in depositing the first and second anchor components in the tissue after needle refraction.
  • the device can be configured with suture guides which provide centering of the suture and/or a stop to hold the suture stable while an anchor is placed on it to ensure a reliable assembly of an anchor assembly.
  • an automated tensioning spring is provided for actuation during the lever retraction, thus providing consistent suture tension during the anchor deployment and making the anchor seating more reliable, as well as minimizing the distance between the two anchors and holding the target tissue approximated.
  • a delivery tool shaft lumen that has at least one flat registration surface to align the anchors to be registered with the tensioned suture as well as a spring-like obstructive tab are used to maintain the most distal anchor in position prior to deployment. Actuation of a final trigger can then translate a pusher element to advance the anchor onto the suture with sufficient speed and force to seat with reliable retention force.
  • FIG. 1 is a left side view, depicting one embodiment of an anchor delivery system
  • FIG. 2 is a perspective view, depicting the anchor delivery system of FIG. 1 ;
  • FIG. 3 is a right side view, depicting the anchor delivery system of FIG. 1 ;
  • FIG. 4 is a side view, depicting the anchor delivery system of FIG. 3 with a portion of the casing removed;
  • FIG. 5 is a left side view, depicting the anchor delivery device of FIG. 1 with a portion of the casing removed;
  • FIG. 6 is an exploded view, depicting the device of FIG. 1 ;
  • FIG. 7 is a perspective view, depicting a needle drive spool assembly
  • FIG. 8 is another perspective view, depicting the needle drive spool assembly of FIG. 7 ;
  • FIG. 9 is an exploded view, depicting the needle drive spool assembly of FIG. 7 ;
  • FIG. 10 is an enlarged view, depicting a portion of the needle drive spool assembly
  • FIG. 11 is an enlarged view, depicting a portion of the needle assembly attached to the needle drive spool assembly
  • FIG. 12 is a perspective view, depicting a cartridge assembly of the delivery device
  • FIG. 13 is a rotated perspective view, depicting the cartridge assembly of FIG. 12 ;
  • FIG. 14 is an exploded view, depicting components of the cartridge assembly
  • FIG. 15 is a side view, depicting a first component of an anchor and anchoring delivery system
  • FIG. 16 is a perspective view, depicting components for attaching components of FIG. 15 to a cartridge assembly
  • FIG. 17 is a perspective view, depicting replacing a cartridge assembly within an anchor delivery device
  • FIG. 18 is a perspective view, depicting attachment of a cartridge assembly to other components of anchor delivery system
  • FIG. 19 is a perspective view, depicting loading a portion of an anchor assembly emerging from a cartridge to pass through a needle assembly within a delivery device;
  • FIG. 20 is a perspective view, depicting a further step involving loading of a cartridge assembly
  • FIG. 21 is a perspective view, depicting yet another step in loading of a cartridge assembly involving advancing a portion of the anchor assembly to a distal end of the delivery device;
  • FIG. 22 is a cross-sectional view, depicting a first step involving an interventional procedure
  • FIG. 23 is a partial cross-sectional view, depicting a delivery device in a non-actuated configuration
  • FIG. 24 is a perspective view partially in cross-section, depicting a distal terminal end of a delivery device
  • FIG. 25 is a partial cross-sectional view, depicting depression of an actuator of a delivery device
  • FIG. 26 is a partial cross-sectional view, depicting disengagement of an actuator of a delivery device
  • FIG. 27 is a perspective view in partial cross-section, depicting partial ejection of a needle assembly
  • FIG. 28 is a perspective view in partial cross-section depicting complete ejection of a needle assembly ejection
  • FIG. 29 is a cross-sectional view, depicting advancement of a needle assembly at an interventional site
  • FIG. 30 is a partial cross-sectional view, depicting a delivery device in a ready state
  • FIG. 31 is a partial cross-sectional view, depicting depression of an actuator of a delivery device
  • FIG. 32 is a partial cross-sectional view, depicting action of components of a delivery device upon depression of an actuator
  • FIG. 33 is a partial cross-sectional view, depicting complete depression of a lever of a delivery system
  • FIG. 34 is a perspective partial cross-sectional view, depicting withdrawal of a needle assembly leaving a connector element
  • FIG. 35 is a cross-sectional view, depicting delivery of a first component of an anchor assembly at an interventional site
  • FIG. 36 is a partial cross-sectional view, depicting positional relationships of internal components of the delivery system upon actuation of an actuator
  • FIG. 37 is a partial cross-sectional view, depicting further action of internal components of the delivery device.
  • FIG. 38 is a partial cross-sectional view, depicting yet further action of internal components of the delivery device.
  • FIG. 39 is a side view, depicting components of a needle drive spool assembly
  • FIG. 40 is a cross-sectional view, depicting components of a needle drive spool assembly
  • FIG. 41 is a side view, depicting action of components of a spool assembly
  • FIG. 42 is a cross-sectional view, depicting the structure of FIG. 41 after actuation;
  • FIG. 43 is a perspective view, depicting components of a cartridge assembly in conjunction with components of a needle drive assembly
  • FIG. 44 is a perspective view, depicting the components of FIG. 43 subsequent to action of an actuator
  • FIG. 45 is a perspective view, depicting further action of the components of FIG. 43 subsequent to action of a retraction lever;
  • FIG. 46 is a perspective view, depicting yet further action of the components of FIG. 43 ;
  • FIG. 47 is a perspective view, depicting a shaft assembly of the delivery device
  • FIG. 48 is a perspective view, depicting structure defining a scope mount
  • FIG. 49 is a perspective view and partial cross-sectional view, depicting a sheath mount assembly
  • FIG. 50 is a perspective view, depicting a cutter assembly of the delivery device
  • FIG. 51 is a perspective view, depicting a terminal end of the cutter assembly of FIG. 50 ;
  • FIG. 52 is a perspective view, depicting a pusher assembly of the delivery device
  • FIG. 53 is a perspective view, depicting a trigger assembly of the delivery device
  • FIG. 54 is an exploded view, depicting the components of the trigger assembly of FIG. 53 ;
  • FIG. 55 is a partial cross-sectional view, depicting the delivery device prior to depression of the retraction lever
  • FIG. 56 is a partial cross-sectional view, depicting the device of FIG. 55 after depression of the retraction lever;
  • FIG. 57 is a partial cross-sectional view, depicting further action of components of the device depicted in FIG. 56 ;
  • FIG. 58 is a partial cross-sectional (inferior) view, depicting action of the trigger assembly
  • FIG. 59 is a partial cross-sectional view, depicting a delivery device readied for depression of the proximal anchor actuator
  • FIG. 60 is a partial cross-sectional view, depicting a depression of the proximal anchor actuator of the device shown in FIG. 59 ;
  • FIG. 61 is a partial cross-sectional view, depicting action of internal components of a delivery device after depression of the proximal anchor actuator;
  • FIG. 62 is a perspective view, depicting advancement of a second anchor component into engagement with a connector
  • FIG. 63 is a cross-sectional view, depicting release of a second anchor component within an interventional site
  • FIG. 64 is a partial cross-sectional view, depicting yet further action of components internal to the delivery device
  • FIG. 65 is a perspective view, depicting cutting of a connector
  • FIG. 66 is a cross-sectional view, depicting release of an assembled anchor assembly within an interventional site
  • FIG. 67 is a cross-sectional view, depicting an untreated interventional site
  • FIG. 68 is a cross-sectional view, depicting implantation of two anchor assemblies at an interventional site.
  • FIG. 69 is an enlarged view of a portion of FIG. 68 .
  • the present disclosure is directed to a device configured to deliver anchor assemblies within a patient's body.
  • the disclosed apparatus can be employed for various medical purposes including but not limited to retracting, lifting, compressing, approximating, supporting or repositioning tissues, organs, anatomical structures, grafts or other material found within a patient's body. Such tissue manipulation is intended to facilitate the treatment of diseases or disorders.
  • the disclosed invention has applications in cosmetic or reconstruction purposes or in areas relating the development or research of medical treatments.
  • the anchor assembly of the present disclosure is contemplated to be formed of a structure which is visible by ultrasound. Accordingly, the anchor assembly can be viewed during ultrasonic body scans such as during normal trans-rectal ultrasound when a medical professional is conducting diagnoses or treatment associated with conditions like prostate cancer.
  • one portion of an anchor assembly or implant is positioned and implanted against a first section of anatomy.
  • a second portion of the anchor assembly or implant is then positioned and implanted adjacent a second section of anatomy for the purpose of retracting, lifting, compressing, approximating, supporting or repositioning the second section of anatomy with respect to the first section of anatomy as well as for the purpose of retracting, lifting, compressing, approximating, supporting or repositioning the first section of anatomy with respect to the second section of anatomy.
  • both a first and second portion of the anchor assembly can be configured to accomplish the desired retracting, lifting, compressing, approximating, supporting or repositioning of anatomy due to tension supplied thereto via a connector assembly affixed to the first and second portions of the anchor assembly or implant.
  • a device 100 is configured to include structure that is capable of both gaining access to an interventional site as well as assembling and implanting one or more anchor assemblies or implants within a patient's body.
  • the device 100 is configured to assemble and implant a single anchor assembly or implant with a replaceable cartridge. If the user replaces the cartridge another anchor assembly or implant can be assembled and implanted.
  • the device is further contemplated to be compatible for use with a 19 F sheath.
  • the device additionally includes structure configured to receive a conventional remote viewing device (e.g., an endoscope) so that the steps being performed at the interventional site can be observed.
  • a conventional remote viewing device e.g., an endoscope
  • the anchor delivery device 100 includes a handle assembly 102 connected to an elongate tissue access assembly 104 .
  • the elongate tissue access assembly 104 houses components employed to construct an anchor assembly and is sized to fit into a 19 F cystosopic sheath for patient tolerance during a procedure in which the patient is awake rather than under general anesthesia.
  • the tissue access assembly is stiff to allow manual compression of tissue at an interventional site by leveraging the handle assembly 102 .
  • the anchor delivery device 100 further includes a number of subassemblies.
  • a handle case assembly 106 including mating handle parts encase the handle assembly 102 .
  • the handle assembly 102 is sized and shaped to fit comfortably within an operator's hand and can be formed from conventional materials. Windows can be formed in the handle case assembly 106 to provide access to internal mechanisms of the device so that a manual override is available to the operator in the event the interventional procedure needs to be abandoned.
  • the delivery device 100 is equipped with various activatable members which facilitate assembly and delivery of an anchor assembly at an interventional site.
  • a needle actuator 108 is provided and as described in detail below, effectuates the advancement of a needle assembly (loaded with a first component of an anchor assembly) to an interventional site.
  • the needle assembly has a needle that moves through a curved trajectory and exits the needle assembly in alignment with the handle element, in particular embodiments, in alignment with the grip.
  • the needle housing is oriented such that the needles exits the housing at either the two o'clock or ten o'clock positions relative to a handle grip that is vertical.
  • a needle retraction lever assembly 110 is also provided and when actuated causes the needle assembly to be withdrawn and expose the first anchor component. This action and the structure involved is also described in detail below.
  • the delivery device 100 is equipped with a rear or proximal anchor actuator assembly 112 which as fully described below, upon actuation, accomplishes assembly of a second component to the anchor assembly and release of the anchor assembly at the interventional site.
  • the case assembly 106 has three mating parts, a left top case 114 , a left bottom case 116 , and a right case 118 . It is within the scope of the present invention that the case assembly be made of a variety of numbers of parts. In addition to mating to enclose subassemblies, the case parts also include structural features for providing rigidity and support for the enclosed components.
  • a needle retract spool assembly 120 Housed within the case assembly 106 are a needle retract spool assembly 120 and a cartridge assembly 122 .
  • the rotational axes of the needle spool assembly and cartridge assembly are the same.
  • a shaft assembly 124 includes a portion residing within the case assembly 106 and a portion extending from a forward end of the case assembly. Attached to and operatively associated with the shaft assembly 124 is a trigger assembly 126 .
  • the trigger assembly 126 is also housed within the case assembly 106 .
  • FIGS. 4 and 5 illustrate the juxtapositional relationships of the various subassemblies and FIG. 6 is an exploded view depicting the subassemblies.
  • the needle retract spool assembly 120 cooperates with the needle actuator and needle retraction lever to advance and then withdraw a needle assembly at an interventional site.
  • the needle retract spool assembly 120 is a compact structure including a number of moving pieces.
  • a needle spring housing 202 forms one side of the assembly 120 and is placed adjacent to a needle spool housing 204 .
  • An outer side of the needle spring housing 202 forms a generally flat surface and formed on the opposite side of the needle spring housing 202 is a circular recess.
  • the circular recess of the needle spring housing 202 faces the needle spool housing 204 .
  • Formed in opposite sides of the needle spool housing 204 are two additional generally circular recesses.
  • a needle deploy spring 206 configured within and adjacent a needle deploy spring arbor 208 , which is adjacent to a needle clutch plate 210 .
  • the needle clutch plate 210 is adjacent and received within a circular recess formed in a needle clutch cup 212 .
  • Received in the needle spool housing 204 recess opposite of the needle spring housing 202 is a needle spool 214 .
  • the needle deploy spring 206 functions to rotate the needle spool 214 and to project a tip of the needle through tissue with force and speed.
  • the device 100 be configured so that the needle is deployed to a single depth to pierce through a predominant population of urethral-prostatic distances.
  • Each of the generally circular profiled needle deploy spring 206 and needle deploy spring arbor 208 include a center through hole. Further, a clutch push rod 216 extends through such aligned holes of a completed assembly from the outer side of the needle spring housing 202 and through the needle deploy spring 206 and needle deploy spring arbor 208 .
  • a pivotable clutch actuator 218 configured on the outside surface of the needle spring housing 202 , as described in further detail below through its interaction with the needle retraction lever, causes lateral movement of the push rod 216 so that it engages the needle clutch plate 210 separating it from the spring arbor 208 .
  • the spring arbor 206 is rotationally biased by the needle deploy spring 206 , which can be formed of a helically arranged motor spring.
  • a needle spring reset lever 220 is further provided, the same being accessible to reset the spring arbor 208 after an initial use.
  • the clutch plate 210 is received within the needle clutch cup 212 .
  • the interior of the clutch cup 212 includes bosses (not shown) sized to mate with corresponding recesses formed in the clutch plate 210 .
  • a center hole formed in the clutch plate 210 is sized to receive a center post extending from an adjacent face of the clutch plate.
  • Such structure facilitates complementary rotation of the clutch plate 210 and clutch cup 212 .
  • Complementary rotational motion of the clutch cup 212 and the needle spool 214 is also accomplished through an interconnection of these pieces through a center hole form in the needle spool housing 204 .
  • the assembly further includes a needle deploy pawl 222 which is operatively associated with the needle actuator. As shown and described below, the needle actuator pivots the needle deploy pawl 222 away from engagement with the spring arbor 208 , thereby permitting rotation of the same.
  • An unsheathing pawl 224 is also provided and configured at one end to engage the needle retraction lever. At another end of the unsheathing pawl 224 there is structure configured to engage a capsular cartridge spool (described below) to thereby fix its rotational position while the needle spool 214 rotates.
  • a proximal end 230 of a needle assembly can be sized and shaped for connecting with other structure.
  • the proximal end of the needle assembly includes a shoulder sized and shaped for receipt within a corresponding recess formed near a periphery of the needle spool 214 .
  • Other approaches to effecting a connection are also contemplated such as using a shear wire (not shown) to engage a recess formed in the end of the needle assembly and hold the needle assembly in place relative to the needle spool.
  • a peripheral recess formed in the needle spool 214 is provided to take up lengths of a needle assembly.
  • FIGS. 12-14 Details of the cartridge assembly 122 are depicted in FIGS. 12-14 .
  • a generally circular profiled suture spool sleeve 302 forms an outer structure of the cartridge assembly 122 .
  • a tensioning spring 308 and a suture spool 310 are positioned between a generally disk shaped suture spool track 304 and a primary knob 306 and within the suture spool sleeve of an assembled cartridge 122 .
  • the tensioning spring 300 functions to provide a tension on a connector member (e.g., a suture) of an anchor assembly.
  • a connector member e.g., a suture
  • Various different cartridges can be provided which embody springs having varying tensions associated therewith.
  • the system can be configured to provide a different tension when advancing the connector member from that generated subsequent to placement of the anchor assembly at an interventional site.
  • the suture spool 310 is configured to releasably engage the unsheathing pawl 224 .
  • FIG. 15 One form of a distal anchor 350 and connector member 352 of an anchor assembly is shown in FIG. 15 .
  • a pusher e.g., a PTFE coated stainless steel wire
  • the connector member 352 e.g., a PET monofilament suture
  • a sleeve e.g., polyimide sleeve
  • An annular space formed about the suture spool 304 is provided to receive a length of the pusher 354 .
  • a particular advantage of this embodiment is that the cartridge assembly 122 is removable and replaceable.
  • a door on the case can be opened or an open window can be in the case to provide access to the interior of the delivery device.
  • the left top case 114 can be removed providing access to an interior of the delivery device.
  • the cartridge assembly 122 can be placed within an outside recess of the spool housing 204 and into engagement with the needle spool 214 .
  • the center post extending from the needle spool 214 helps guide the cartridge assembly 122 perpendicularly to the needle spool 214 .
  • the primary knob 306 of the cartridge assembly 122 is rotated ( FIGS. 20-21 ) to advance the leading terminal end and connector portion of the anchor assembly through the hole 366 then through the length of the needle assembly (See FIGS. 10-11 ).
  • the primary knob 306 is continued to be rotated until the knob follower 312 registers at a completion point to thereby signal that the anchor assembly is fully loaded within the needle assembly and in one embodiment the leading end of the anchor assembly is just proximal the distal opening of the needle.
  • the elongate tissue access portion 104 of a delivery device is placed within a urethra (UT) leading to a urinary bladder (UB) of a patient.
  • the elongate portion 104 is advanced within the patient until a leading end 400 thereof reaches a prostate gland (PG).
  • the delivery device 100 is at this stage configured in a ready state.
  • the needle actuator 108 and the needle retracting lever 110 are in an inactivated position.
  • the needle actuator 108 is spring biased by a rotating biasing assembly 402 .
  • a needle actuator safety (not shown) can be included to lock the needle trigger 108 in an inactive position.
  • a lock-out cam assembly 404 is rotated ninety degrees thereby permitting subsequent actuation of the needle retracting lever 110 .
  • the assembly further includes a lever lock 406 configured to hold the depressed needle retracting lever after retraction of the lever 110 . It is at this stage also that the terminal end 400 of the elongate portion 104 of the delivery device houses a completely withdrawn needle assembly 410 and further includes a second anchor assembly component 450 registered for later deployment (See FIG. 24 ).
  • Initial depression of the needle actuator 108 causes components of the biasing assembly 402 to pivot (See FIG. 25 ). Releasing the needle actuator 108 facilitates it returning to an undepressed condition and permits the lock-out cam assembly 404 to rotate ninety degrees (See FIG. 26 ). In this position, the lock-out cam assembly 404 is positioned to permit actuation of the needle retraction lever 110 .
  • the needle assembly is advanced from within the elongate member 104 .
  • the needle is ejected by the needle deploy spring 206 in this embodiment in a direction commensurate with the direction the handle assembly extends.
  • the needle assembly can be configured so that it curves back toward the handle as it is ejected.
  • the needle assembly 410 is advanced through and beyond a prostate gland (PG).
  • PG prostate gland
  • the spring deployment helps to ensure the needle tip passes swiftly through the tough outer capsule of the prostate without “tenting” the capsule or failing to pierce the capsule.
  • the needle could be manually deployed by the user.
  • the needle 410 is made from Nitinol tubing and can be coated with Parylene N. Such a coating helps compensate for frictional or environmental losses (i.e. wetness) which may degrade effectiveness of needle penetration.
  • FIG. 30 shows the needle actuator 108 in an unactuated state.
  • the needle actuator 108 As the needle actuator 108 is depressed ( FIG. 31 ), it rotates and an extension thereof engages the needle deploy pawl 222 .
  • Continual depression of the needle actuator FIG. 32 ) causes the needle pawl 222 to rotate from its engagement with the needle deploy spring arbor 208 .
  • This disengagement then permits the needle deploy spring 206 to rotate the needle deploy arbor 208 , clutch plate 210 , needle clutch cup 212 and needle spool 214 (See FIG. 9 ).
  • Rotational motion of the needle deploy spring arbor 208 can be observed by noting the change in position of the needle spring reset lever 220 . Again, through its connection with a needle assembly, rotation of the needle spool 214 causes the needle assembly to be advanced a desired distance.
  • the needle retraction lever 110 can be completely actuated (See FIG. 33 ).
  • the lever lock 406 engages and locks the lever 110 in place.
  • the lever lock 406 can be later manipulated to unlock the lever 110 .
  • Such action results in a withdrawal of the needle assembly 410 , leaving the connector 352 of an anchor assembly in an extended position (See FIG. 34 ).
  • the connector 352 extends through the needle window and is centered by suture guide structure.
  • FIG. 35 in a prostatic interventional procedure, the same results in configuring a first or distal anchor component beyond an outer surface of a prostate gland (PG) with the connector 352 extending toward the terminal end 400 of a delivery device.
  • PG prostate gland
  • actuation of the needle retraction lever 110 causes the rotation of the pivotable clutch actuator 218 (See FIGS. 31-38 ). As shown in FIG. 36 , the clutch actuator 218 is in a home position. Upon actuation of the lever 110 , the clutch actuator 218 rotates (See FIG. 37 ).
  • the tensioning spring 308 provides the tension forces which helps to ensure the distal anchor is pulled back into firm contact with a desired tissue plane such as, for example, the outer capsular surface of the prostate gland.
  • a desired force such as up to 1-2 pounds or more of tension.
  • a spring can be used to automatically retract the needle assembly.
  • the timing of the needle retraction and tensioning is accomplished through the interaction of the unsheathing pawl 224 and the needle spool 214 .
  • the unsheathing pawl 224 is configured to permit a clockwise rotation of the needle spool which occurs during needle actuator depression until the unsheathing pawl 224 registers within grooves formed in the needle spool.
  • Actuation of the needle retraction lever 110 causes a deflection of the unsheathing pawl 224 (See also FIG. 38 ) which disengages the unsheathing pawl 224 from the needle spool 214 .
  • the needle spool 214 Since the needle spool 214 is at this point disengaged from the operation of the spring arbor as described above, the needle spool 214 is permitted to rotate in a counterclockwise direction as illustrated in FIG. 46 . This counterclockwise rotation continues until the unsheathing pawl 224 again registers in recesses 516 formed in the needle spool 214 ( FIG. 46 ). Such recesses can be spaced to provide desired corresponding needle depths. Also, this structure can be equipped with a roller-clutch (not shown) which would provide a continuous process of longitudinal movement. The tensioning spring of the cartridge assembly 122 (See FIG. 14 ) is then left to automatically provide a consistent tensioning force on a connector of an anchor assembly.
  • the connector gets pulled into suture guide structure 411 (see FIG. 34 ) to center the connector and ready it for engagement with a second anchor component.
  • Such tensioning results in seating a distal or first anchor component 350 as desired within an interventional site such as shown in FIG. 35 as well as to minimize a distance between two anchor members of an implanted anchor assembly.
  • the tension generated after seating the anchor component 350 can be different from that during delivery of the connector of the anchor assembly.
  • a trigger assembly (described below) is mounted to the shaft assembly 124 and the shaft assembly 124 includes components residing within the device case assembly 106 as well as structure extending therefrom.
  • a terminal end portion 400 of the shaft assembly 124 includes an atraumatic tip sleeve 502 .
  • Proximally located to the tip sleeve 502 is a tubular shaft assembly 504 which is sized and shaped to slidably receive the needle assembly.
  • a distal end portion of the tubular shaft assembly 504 is curved so that a needle projecting therefrom extends in a direction generally corresponding to that of the handle of the delivery device.
  • a scope tube 506 Configured longitudinally adjacent the tubular shaft assembly is a scope tube 506 which is sized and shaped to receive a scope. Configured below and longitudinally adjacent the scope tube 506 is an elongate cover 507 which is sized to receive elongate portions of the cutter and pusher assemblies.
  • a scope mount lock screw assembly 508 At a proximal end of the shaft assembly 124 is a scope mount lock screw assembly 508 .
  • a sheath mount assembly 510 including a screw lock 512 is spaced distal and longitudinally from the scope mount assembly 508 .
  • Configured between these assemblies are components of a cutter assembly 514 and a pusher assembly 516 . It is to be recognized, however, that both the cutter and pusher assemblies include elongate portions extending toward a distal end 400 of the shaft assembly 124 .
  • the scope mount lock screw assembly 508 includes a screw lock 520 rotatably positioned adjacent a scope mount receiver 522 .
  • the scope mount assembly further includes a handle pusher support snap fit 524 .
  • the scope mount lockingly engages a scope 550 which has a longitudinal dimension sufficient to extend longitudinally substantially a length of the scope tube 506 .
  • the sheath mount 510 can be screwed to elongate portions of the shaft assembly (See FIG. 49 ).
  • the sheath mount 510 can include a seal 530 which functions to seal and minimize fluid ingress into the handle portion of a delivery device.
  • an embodiment of the cutter assembly 514 includes a cutter plate 560 supporting a distally directed, elongate cutter tube 562 and a guide 564 .
  • a pair of spring extensions 566 are also provided and are each configured to be attached to a cutter spring.
  • a distal end 568 of the cutter tube 562 is configured with a blade so that once cutter springs are permitted to withdraw the cutter assembly 514 , the blade can sever as desired a connector of an anchor assembly.
  • the pusher assembly 516 includes an elongate pusher member 580 extending from a pusher block 582 to a pusher extension 584 .
  • the pusher extension 584 engages a proximal end of a second or proximal anchor component.
  • the pusher block 582 further includes a plurality of recesses 586 sized and shaped to receive corresponding structure of the trigger assembly.
  • the assembly 126 includes a base 602 and a frame 604 to which other components are affixed or supported.
  • a lever pivot 606 is rotatably attached to a proximal anchor actuator assembly 608 .
  • the lever pivot 606 is rotated through action of the lever from a first position where it locks the rear or proximal anchor actuator 608 against actuation to a second position where actuation of the proximal anchor actuator is possible.
  • Eventual actuation of the proximal anchor actuator assembly 608 causes a deflection of a trigger 610 which releases a tripper 612 having cammed surfaces.
  • a first pawl 614 is further provided and placed against both the camming surfaces of the tripper 612 and into recesses formed in the pusher block of the above disclosed pusher assembly.
  • a second pawl 616 follows the action of the first pawl 614 to engage as desired the pusher block.
  • a cutter pawl 618 is also placed into engagement with camming surfaces of the tripper 612 , the cutter pawl cooperating to actuate the cutter assembly.
  • the trigger assembly 126 also includes a reset lever 620 and a cutter bailout assembly 622 including a biasing spring 624 , operation of which will be described below. It is to be recognized, however, that the system can be configured such that manipulation of the needle retract lever, for example, can accomplish resetting the device as well as the bailout function.
  • FIGS. 55-58 an embodiment of the anchor delivery is shown in cross-section to illustrate locked and unlocked configurations of the trigger assembly 126 .
  • the needle actuator 108 and needle refractor lever 110 are in a non-actuated position and the lever pivot 606 is in a first position locking the button pad assembly 608 against actuation.
  • the lever pivot 606 is rotated out of engagement with the proximal anchor actuator assembly 608 .
  • the proximal anchor actuator 608 is unlocked and can be depressed (See FIG. 57 ).
  • the proximal anchor actuator assembly 608 translates longitudinally to rotate the trigger 610 out of locking engagement with the tripper 612 . This, in turn, initiates the action of the trigger assembly 126 .
  • FIG. 59 the trigger assembly 126 is shown prior to actuation.
  • the proximal anchor actuator 608 is readied for depression and the trigger 612 is in its longitudinally distal position.
  • the first pawl 614 is in a first position in locking engagement with the pusher 582 of the pusher assembly (See Also FIG. 58 ).
  • proximal anchor actuator assembly 608 Pressing the proximal anchor actuator assembly 608 , as above stated, releases the tripper 612 . Being biased by a spring assembly 650 , upon release the tripper 612 moves proximally relative to an operator (See FIG. 60 ). As it moves proximally, camming surfaces on the tripper 612 rotate the first pawl out of engagement with the pusher 582 . This action results in the release of the pusher assembly (See also FIG. 52 ) to move longitudinally in the distal direction. Control of the longitudinal translation of the pusher assembly is maintained by the second pawl 616 which follows movement of the first pawl, and which rotates to again lock the pusher 662 .
  • release of the pusher assembly accomplishes advancing the pusher thereof distally resulting in advancing a second component 450 of an anchor assembly into locking engagement with a connector of an anchor assembly (See FIG. 62 ).
  • Such action causes the pusher 582 to advance an anchor component 450 onto a connector (e.g., a suture) with sufficient speed and force to seat the anchor 450 with reliable retention force.
  • a connector e.g., a suture
  • the anchor assembly is configured across anatomy within the interventional site. Longitudinally displaced cutter cam surfaces formed on the tripper 612 then subsequently engage the cutter pawl 618 to rotate it out of engagement with the cutter assembly (See FIGS.
  • FIG. 64 The resultant implanted anchor assembly 700 is shown in FIGS. 65 , 68 and 69 .
  • FIG. 65 , 68 and 69 The resultant implanted anchor assembly 700 is shown in FIGS. 65 , 68 and 69 .
  • FIG. 67 depicts a partial cross-sectional view of an untreated interventional site of the urethra (UT) narrowed by the surrounding enlarged prostate tissue.
  • the delivery device 100 can be configured to retain and deploy multiple second anchor components 450 .
  • the anchor components 450 are placed in-line and arranged such that a single anchor component is advanced one deployed anchor length with each trigger actuation. Upon reset of the trigger assembly a next sequential anchor component is readied for deployment.
  • the cover 507 can be configured with a spring-like distal tab 710 which engages a slot formed in the second to most distally positioned anchor component and which facilitates maintaining proper positioning of the most distal anchor prior to deployment.
  • the cover 507 can further be equipped with a proximal suture slot (not shown) and include an interior arranged to include at least one flat registration surface to align anchor components 450 with connector members 352 (See FIG.
  • the distal end of the delivery device can be equipped with a flexible/elastomer cover. This cover shields the anchor deployment space to ensure reliable anchor seating on connector and to allow for ejection of an implant from a delivery tool.
  • FIG. 65 the distal end of the delivery device is shown within cystoscopic sheath 712 .
  • the second anchor component can be embodied in a slotted anchor configured to secure to a connector.
  • the slotted proximal anchor can include a flattened-tubular back end that resembles a flattened tube in shape, with a width in lateral cross-section that is greater than its thickness.
  • the slotted proximal anchor also includes a pair of spaced apart prongs extending from the back end of the slotted proximal anchor to the front end of the slotted proximal anchor. The spaced prongs join together at a slot inception.
  • the prongs are shaped and sized of a configuration and of a rigidity to substantially prevent deflection of the prongs.
  • the prongs can include inwardly facing protrusions that are configured to capture and deform the connector between the protrusions and prevent the connector from disengaging from the slotted anchor device once engaged.
  • the mechanism of suture attachment and strength of the assembly is a combination of compression of the suture between the stiff slotted prongs of the anchor as well as disruption of the suture surface by the discreet edges of the slotted, flattened-tubular anchor.
  • the discreet edges provide a lower contact surface area between anchor prongs and suture and focuses the compressive forces in focal points that cause the suture to conform around both internal recesses and external faces.
  • various further embodiments of slotted anchors or anchors forming a clip are also contemplated.
  • various embodiments of structures which accordingly provide alternative approaches to attach to a connector can be employed. That is, the anchors can be deformable, deflectable, latching, nested, meltable and/or coiled in structure.
  • the present invention contemplates both pushing directly on anchor portions of an anchor assembly as well as pushing directly upon the connector of the anchor assembly.
  • the distal or first anchor component is advanced and deployed through a needle assembly and at least one component of the proximal or second anchor component is advanced and deployed from a housing portion of the anchor deployment device.
  • both a single anchor assembly or multiple anchor assemblies can be delivered and deployed at an intervention site by the deployment device. Consequently, in the context of prostate treatment, the present invention is used for the compression of the prostate gland and the opening of the prostatic urethra, the delivering of an implant at the interventional site, and applying tension between ends of the implant.
  • drug delivery is both contemplated and described as a further remedy in BPH and over active bladder treatment as well as treating prostate cancer and prostatitis.
  • the anchor assembly of the present invention accomplishes desired tissue manipulation, compression or retraction as well as cooperates with the target anatomy to provide an atraumatic support structure.
  • the shape and contour of the anchor assembly 700 is configured so that the assembly invaginates within target tissue, such as within natural folds formed in the urethra by the opening of the urethra lumen by the anchor assembly (See FIGS. 68-69 ).
  • target tissue such as within natural folds formed in the urethra by the opening of the urethra lumen by the anchor assembly (See FIGS. 68-69 ).
  • wispy or pillowy tissue in the area collapses around the anchor structure.
  • the natural tissue can grow over the anchor assembly 700 and new cell growth occurs over time (see FIG. 69 ).
  • Such cooperation with target tissue facilitates healing and avoids unwanted side effects such as calcification or infection at the interventional site.
  • the disclosed anchor delivery device can be configured for multiple or single use.
  • multiple or a single first anchor component can be loaded within the delivery device via a cartridge assembly, which is a removable and replaceable assembly.
  • multiple or a single second anchor component can be configured within the shaft assembly such as shown in FIG. 34 .
  • the second anchor components can be lined up end to end within the shaft assembly with a proximal most second anchor component being placed into engagement with a lead end of the pusher assembly.
  • the spool assembly of the delivery device can be reset for further use through the manipulating of the reset lever 220 (See FIGS. 30-32 , 36 - 38 ).
  • An initial step in resetting the device would involve releasing the needle retraction lever 110 from its engagement with the locking mechanism 406 (See FIG. 33 ).
  • the trigger assembly can be reset through the actuator of the trigger reset lever 620 .
  • Manners in which healing can be promoted can include employing abrasive materials, textured connectors, biologics and drugs.
  • one portion of an anchor assembly can be placed within an urethra and a second component beyond the outer surface of the prostate. It has been found that implanting the anchor assemblies by using the distal end of the device to displace the prostate lobe on either side (while the tension spring is taking up slack in the connector after the delivery needle has been refracted) while deploying the second anchor component so that the ten o'clock and two o'clock positions (when looking along the axis of the urethra) are supported or retained, effectively holds the anatomy open and also facilitates invagination of the anchor portion within natural tissue. This is particularly true in the regions of anatomy near the bladder and the juncture at which the ejaculatory duct connects to the urethra.
  • the anchor assembly may be coated or embedded with therapeutic or diagnostic substances (e.g. drugs or therapeutic agents).
  • therapeutic or diagnostic substances e.g. drugs or therapeutic agents.
  • the anchor assembly can be coated or imbedded with substances such as 5-alpha-reductase which cause the prostate to decrease in size.
  • Other substances contemplated include but are not limited to phytochemicals generally, alpha-1a-adrenergic receptor blocking agents, smooth muscle relaxants, and agents that inhibit the conversion of testosterone to dihydrotestosterone.
  • the connector 95 can for example, be coated with a polymer matrix or gel coating which retains the therapeutic or diagnostic substance and facilitates accomplishing the timed release thereof.
  • bacteriostatic coatings as well as analgesics and antibiotics for prostatitis and other chemical coatings for cancer treatment, can be applied to various portions of the anchor assemblies described herein.
  • Such coatings can have various thicknesses or a specific thickness such that it along with the connector itself matches the profile of a cylindrical portion of an anchor member affixed to the connector.
  • the co-delivery of a therapeutic or diagnostic gel or other substances through the implant deployment device or another medical device (i.e. catheter), and moreover an anchor assembly including the same is within the scope of the present invention as is radio-loading devices (such as a capsular or distal ends of implants for cancer or other treatment modalities).
  • the deployment device includes a reservoir holding the gel substance and through which an anchor device can be advance to pick up a desired quantity of therapeutic or diagnostic gel substance.
  • the timing of the dual advancement of the needle and connector assemblies and subsequent relative motion between the assemblies is coordinated. That is, the needle assembly first provides access to an interventional site and then the connector assembly is left extending beyond a terminal end of the needle assembly through the relative motion of the needle and connector assemblies.
  • the anchor delivery device can include the ability to detect forces being applied thereby or other environmental conditions.
  • Various sections of the device can include such devices and in one contemplated approach sensors can be placed along the needle assembly. In this way, an operator can detect for example, whether the needle has breached the target anatomical structure at the interventional site and the extent to which such breaching has occurred.
  • Other sensors which can detect particular environmental features can also be employed such as blood or other chemical or constituent sensors.
  • one or more pressure sensors or sensors providing feedback on the state of deployment of the anchor assembly during delivery or after implantation are contemplated. For example, tension or depth feedback can be monitored by these sensors. Further, such sensors can be incorporated into the anchor assembly itself, other structure of the deployment device or in the anatomy.
  • connection of an anchor assembly can be severed and a proximal (or second) anchor component removed from the patient's body.
  • the physician can simply cut the connector and simultaneously remove the second anchor previously implanted for example, in the patient's urethra using electrosurgical, surgical or laser surgical devices used in performing transurethral prostate resection.
  • An aspect that the various embodiments of the present invention provide is the ability to deliver multiple, anchor assemblies having a customizable length and distal anchor components, each anchor assembly being implanted at a different location without having to remove the device from the patient.
  • the various embodiments provide for variable needle depth and variable connector length for each of the multiple anchor assemblies delivered.
  • Other aspects of the various embodiments of the present invention are load-based delivery, preferably 1 pound, of an anchor assembly, anchor assembly delivery with a device having integrated connector, (e.g. suture), cutting, and anchor assembly delivery with an endoscope in the device.
  • the delivery device is uniquely configured to place such a load (half pound to five pounds) between spaced first anchor members as well as between or on an implanted first anchor to help ensure that the first anchor component sits firmly against a tissue plane (e.g., the outer capsule of the prostate) and is held relatively firm as the second anchor component is attached to the connector and the delivery device.
  • a tissue plane e.g., the outer capsule of the prostate
  • the needle assembly acting as a penetrating member can be cooperatively connected to a mechanism which produces a desired tension between the various anchor members while the needle assembly is retracted.
  • this load can be accomplished between first and second implanted anchor members.
  • one or more components such as distal anchor, proximal anchor, connector, of the one or more anchor devices disclosed herein may be designed to be completely or partially biodegradable or biofragmentable.
  • the devices and methods disclosed herein may be used to treat a variety of pathologies in a variety of lumens or organs comprising a cavity or a wall.
  • lumens or organs include, but are not limited to urethra, bowel, stomach, esophagus, trachea, bronchii, bronchial passageways, veins (e.g. for treating varicose veins or valvular insufficiency), arteries, lymphatic vessels, ureters, bladder, cardiac atria or ventricles, uterus, fallopian tubes, etc.

Abstract

A system and associated method for manipulating tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders or other purposes. In one aspect, the system includes a delivery device configured to deploy and implant anchor devices for such purposes.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • This application is a continuation-in-part of copending U.S. patent application Ser. No. 11/775,162 entitled Multi-Actuating Trigger Anchor Delivery System, filed Jul. 9, 2007, which is a continuation-in-part of copending U.S. patent application Ser. No. 11/671,914, entitled Integrated Handle Assembly For Anchor Delivery System, filed Feb. 6, 2007, which is a continuation-in-part of copending U.S. patent application Ser. No. 11/492,690, entitled Apparatus and Method for Manipulating or Retracting Tissue and Anatomical Structure, filed on Jul. 24, 2006, which is a continuation-in-part of copending U.S. patent application Ser. No. 11/318,246, entitled Devices, Systems and Methods for Retracting, Lifting, Compressing, Supporting or Repositioning Tissues or Anatomical Structures, filed on Dec. 22, 2005, which is a continuation-in-part of copending U.S. patent application Ser. No. 11/134,870 entitled Devices, Systems and Methods for Treating Benign Prostatic Hyperplasia and Other Conditions, filed on May 20, 2005, the entire disclosures of which are expressly incorporated herein by reference and claims the benefit of Provisional Application Ser. No. 61/084,937.
  • FIELD OF THE INVENTION
  • The present invention relates generally to medical devices and methods, and more particularly to systems and associated methods for manipulating or retracting tissues and anatomical or other structures within the body of human or animal subjects for the purpose of treating diseases or disorders and/or for cosmetic or reconstructive or other purposes.
  • BACKGROUND OF THE INVENTION
  • There are a wide variety of situations in which it is desirable to lift, compress or otherwise reposition normal or aberrant tissues or anatomical structures (e.g., organs, ligaments, tendons, muscles, tumors, cysts, fat pads, etc.) within the body of a human or animal subject. Such procedures are often carried out for the purpose of treating or palliating the effects of diseases or disorders (e.g., hyperplasic conditions, hypertrophic conditions, neoplasias, prolapses, herniations, stenoses, constrictions, compressions, transpositions, congenital malformations, etc.) and/or for cosmetic purposes (e.g., face lifts, breast lifts, brow lifts, etc.) and/or for research and development purposes (e.g., to create animal models that mimic various pathological conditions). In many of these procedures, surgical incisions are made in the body and laborious surgical dissection is performed to access and expose the affected tissues or anatomical structures. Thereafter, in some cases, the affected tissues or anatomical structures are removed or excised. In other cases, various natural or man made materials are used to lift, sling, reposition or compress the affected tissues.
  • Benign Prostatic Hyperplasia (BPH)
  • One example of a condition where it is desirable to lift, compress or otherwise remove a pathologically enlarged tissue is Benign Prostatic Hyperplasia (BPH). BPH is one of the most common medical conditions that affect men, especially elderly men. It has been reported that, in the United States, more than half of all men have histopathologic evidence of BPH by age 60 and, by age 85, approximately 9 out of 10 men suffer from the condition. Moreover, the incidence and prevalence of BPH are expected to increase as the average age of the population in developed countries increases.
  • The prostate gland enlarges throughout a man's life. In some men, the prostatic capsule around the prostate gland may prevent the prostate gland from enlarging further. This causes the inner region of the prostate gland to squeeze the urethra. This pressure on the urethra increases resistance to urine flow through the region of the urethra enclosed by the prostate. Thus the urinary bladder has to exert more pressure to force urine through the increased resistance of the urethra. Chronic over-exertion causes the muscular walls of the urinary bladder to remodel and become stiffer. This combination of increased urethral resistance to urine flow and stiffness and hypertrophy of urinary bladder walls leads to a variety of lower urinary tract symptoms (LUTS) that may severely reduce the patient's quality of life. These symptoms include weak or intermittent urine flow while urinating, straining when urinating, hesitation before urine flow starts, feeling that the bladder has not emptied completely even after urination, dribbling at the end of urination or leakage afterward, increased frequency of urination particularly at night, urgent need to urinate etc.
  • In addition to patients with BPH, LUTS may also be present in patients with prostate cancer, prostate infections, and chronic use of certain medications (e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine etc.) that cause urinary retention especially in men with prostate enlargement.
  • Although BPH is rarely life threatening, it can lead to numerous clinical conditions including urinary retention, renal insufficiency, recurrent urinary tract infection, incontinence, hematuria, and bladder stones.
  • In developed countries, a large percentage of the patient population undergoes treatment for BPH symptoms. It has been estimated that by the age of 80 years, approximately 25% of the male population of the United States will have undergone some form of BPH treatment. At present, the available treatment options for BPH include watchful waiting, medications (phytotherapy and prescription medications), surgery and minimally invasive procedures.
  • For patients who choose the watchful waiting option, no immediate treatment is provided to the patient, but the patient undergoes regular exams to monitor progression of the disease. This is usually done on patients that have minimal symptoms that are not especially bothersome.
  • Surgical procedures for treating BPH symptoms include Transurethal Resection of Prostate (TURP), Transurethral Electrovaporization of Prostate (TVP), Transurethral Incision of the Prostate (TUIP), Laser Prostatectomy and Open Prostatectomy.
  • Minimally invasive procedures for treating BPH symptoms include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
  • The most effective current methods of treating BPH carry a high risk of adverse effects. These methods and devices either require general or spinal anesthesia or have potential adverse effects that dictate that the procedures be performed in a surgical operating room, followed by a hospital stay for the patient. The methods of treating BPH that carry a lower risk of adverse effects are also associated with a lower reduction in the symptom score. While several of these procedures can be conducted with local analgesia in an office setting, the patient does not experience immediate relief and in fact often experiences worse symptoms for weeks after the procedure until the body begins to heal. Additionally all device approaches require a urethral catheter placed in the bladder, in some cases for weeks. In some cases catheterization is indicated because the therapy actually causes obstruction during a period of time post operatively, and in other cases it is indicated because of post-operative bleeding and potentially occlusive clot formation. While drug therapies are easy to administer, the results are suboptimal, take significant time to take effect, and often entail undesired side effects.
  • Urinary Incontinence (UI)
  • Many women experience loss of bladder control following childbirth or in old age. This condition is broadly referred to as urinary incontinence (UI). The severity of UI varies and, in severe cases, the disorder can be totally debilitating, keeping the patient largely homebound. It is usually associated with a cystocele, which results from sagging of the neck of the urinary bladder into or even outside the vagina
  • The treatments for UI include behavioral therapy, muscle strengthening exercises (e.g., Kegel exercises), drug therapy, electrical stimulation of the pelvic nerves, use of intravaginal devices and surgery.
  • In severe cases of UI, surgery is generally the best treatment option. In general, the surgical procedures used to treat UI attempt to lift and support the bladder so that the bladder and urethra are returned to their normal positions within the pelvic cavity. The two most common ways of performing these surgeries is through incisions formed in the abdominal wall or though the wall of the vagina.
  • A number of different surgical procedures have been used to treat UI. The names for these procedures include the Birch Procedure, Marshall-Marchetti Operation, MMK, Pubo-Vaginal Sling, Trans-Vaginal Tape Procedure, Urethral Suspension, Vesicourethral Suspension. These procedures generally fall into two categories, namely a) retropubic suspension procedures and b) sling procedures.
  • In retropubic suspension procedures, an incision is typically made in the abdominal wall a few inches below the navel and a network of connectors are placed to support the bladder neck. The connectors are anchored to the pubic bone and to other structures within the pelvis, essentially forming a cradle which supports the urinary bladder.
  • In sling procedures, an incision is typically made in the wall of the vagina and a sling is crafted of either natural tissue or synthetic (man-made) material to support the bladder neck. Both ends of the sling may be attached to the pubic bone or tied in front of the abdomen just above the pubic bone. In some sling procedures a synthetic tape is used to form the sling and the ends of the synthetic tape are not tied but rather pulled up above the pubic bone.
  • The surgeries used to treat UI are generally associated with significant discomfort as the incisions heal and may require a Foley or supra-pubic urinary catheter to remain in place for at least several days following the surgery. Thus, there exists a need in the art for the development of minimally invasive (e.g., non-incisional) procedures for the treatment of UI with less postoperative discomfort and less requirement for post-surgical urinary catheterization.
  • Cosmetic or Reconstructive Tissue Lifting and Repositioning
  • Many cosmetic or reconstructive surgical procedures involve lifting, compressing or repositioning of natural tissue, natural tissue or artificial grafts or aberrant tissue. For example, surgical procedures such as face lifts, brow lifts, neck lifts, tummy tucks, etc. have become commonplace. In many cases, these procedures are performed by creating incisions through the skin, dissecting to a plane beneath muscles and fascia, freeing the muscles, fascia and overlying skin from underlying structures (e.g., bone or other muscles), lifting or repositioning the freed muscles, fascia and overlying skin and then attaching the repositioned tissues to underlying or nearby structures (e.g., bone, periostium, other muscles) to hold the repositioned tissues in their new (e.g., lifted) position. In some cases excess skin may also be removed during the procedure.
  • There have been attempts to develop minimally invasive devices and methods for cosmetic lifting and repositioning of tissues. For example, connector suspension lifts have been developed where one end of a standard or modified connector thread is attached to muscle and the other end is anchored to bone, periostium or another structure to lift and reposition the tissues as desired. Some of these connector suspension techniques have been performed through cannulas or needles inserted though relatively small incisions of puncture wounds.
  • There remains a need for the development of new devices and methods that may be used for various procedures where it is desired to lift, compress, support or reposition tissues or organs within the body with less intraoperative trauma, less post-operative discomfort and/or shorter recovery times. Further, there is a need for an apparatus and related method which is easy and convenient to repeatedly employ in an interventional procedure. In particular, there is an apparatus which can accomplish accessing an interventional site as well as be reused after reloading. Moreover, there is a need for a device including manual as well as automatic features so that successful use is facilitated.
  • The present invention addresses these and other needs.
  • SUMMARY OF THE INVENTION
  • Briefly and in general terms, the present invention is directed towards an apparatus and method for deploying an anchor assembly within a patient's body. The apparatus of the present invention includes various subassemblies which are mobilized via a trigger or other manually accessible structure. The operation of the subassemblies is coordinated and synchronized to ensure accurate and precise implantation of an anchor assembly. Structure for re-loading of the device is also described.
  • In one embodiment, the delivery device is embodied in a tissue approximation assembly. The tool includes a case assembly enclosing a trigger assembly, a needle spool assembly and a replaceable cartridge assembly. Extending from the case assembly and attached to the trigger assembly and needle spool assembly is a shaft assembly. Also, extending through the shaft assembly and connected to the trigger assembly are a pusher assembly, needle, and a cutter assembly. Operatively associated with the needle spool and cartridge assemblies are a needle actuator and a needle retraction actuator (e.g., a lever assembly). A rear actuator is operatively associated with the trigger assembly. This actuator can be positioned on a side of the instrument and can also be incorporated into the lever. It is also contemplated that each of the actuators can be incorporated into a single structure for creating movement of internal mechanisms of the device. Activation of the needle actuator accomplishes the advancement of a needle assembly and a first component of an anchor assembly attached to a connector member, to an interventional site. Activation of the needle retraction actuator withdraws the needle assembly leaving the first component of the anchor assembly at the interventional site. Thereafter, manipulation of the rear actuator results in lockingly engaging a second anchor component with the connector member and cutting the connector member to a desired length.
  • In one particular aspect, the present invention is directed towards a delivery device which accomplishes the delivery of a first or distal anchor assembly component at a first location within a patient's body and the delivery of a second or proximal anchor assembly component at a second location within the patient. The device also accomplishes imparting a tension during delivery and a tension between implanted anchor components as well as cutting the anchor assembly to a desired length and assembling the proximal anchor in situ. The procedure can be viewed employing a scope inserted in the device. Also, the delivery device can be sized and shaped to be compatible with a sheath in the range of 18 to 24 F, preferably a 19 F sheath.
  • Additionally, in a contemplated embodiment of an anchor delivery system, actuating a needle deploy actuator results in a needle assembly being advanced within a patient to an interventional site. Activating a needle retraction lever accomplishes the withdrawal of the needle and deployment of a first anchor component of an anchor assembly at the interventional site. Depression of a second actuator facilitates the incorporation of a second component into the anchor assembly and its release at the interventional site. A reset assembly is further provided to reset aspects of the delivery system as is a bail out assembly configured to release anchor structure from the delivery device. Moreover, various locking mechanisms are provided for both operational as well as safety reasons.
  • The present invention also contemplates a reversible procedure as well as an anchor assembly with sufficient visibility when viewed ultrasonically, by xray, MRI or other imaging modalities. In one aspect, the implant procedure is reversible by severing a connector of an anchor assembly and removing an anchor of the anchor assembly such as by removing a proximally placed anchor previously implanted in an urethra. Moreover, the anchor assemblies can be formed of structures such as that having increased density to thereby facilitate ultrasound viewing or other imaging modalities.
  • The anchor assembly can be configured to accomplish retracting, lifting, compressing, supporting or repositioning tissue within the body of a human or animal subject. Moreover, the apparatus configured to deploy the anchor assembly as well as the anchor assembly itself are configured to complement and cooperate with body anatomy. Further, the anchor assembly may be coated or imbedded with therapeutic or diagnostic substances, in particular Botulinum toxin, or a silver ion coating or such substances can be introduced into or near an interventional site by the anchor deployment device or other structure.
  • In one embodiment, the anchor delivery device includes a handle assembly with a actuator attached thereto. The actuator is associated with a body of the handle assembly and is operatively attached to the needle assembly and structure that advances the first anchor member. A second actuator is operatively associated with structure that accomplishes assembling the second anchor member to the connector member. Additionally, the handle assembly is equipped with structure that is configured in one contemplated embodiment, to effect the cutting of the anchor assembly to a desired length and deployment of the structure at an interventional site.
  • In a specific embodiment, the anchor delivery device includes a generally elongate tubular housing assembly member extending distally from a handle assembly including an actuator. The proximal end of the handle assembly is equipped with mounting structure configured to receive a telescope or other endoscopic viewing instrument. A bore sized to receive the telescope extends distally through a body of the handle assembly and continues through an outer tubular cover member forming the generally elongate member. Housed within the tubular housing assembly are a telescope tube having an interior defining a distal section of the bore sized to receive the telescope, an upper tubular member assembly sized to receive at least one component of the implant assembly through a needle housing configured to receive the needle assembly, and a lower tubular member assembly sized to receive at least one second component of the implant assembly through a cutter member.
  • Additionally, in a preferred embodiment the first anchor member includes a tubular portion, a mid-section and a tail portion. The tail portion of the member further includes a connector section which acts as a resilient member. A terminal end portion of the tail is further contemplated to have a surface area larger than the connector section to provide a platform for engaging tissue.
  • Further, in the preferred embodiment, one component of the second anchor member is embodied in a pin having a first end equipped with a pair of spaced arms and a second end defining a flattened tube.
  • Moreover, various alternative methods of use are also contemplated. That is, in some applications of the invention, the invention may be used to facilitate volitional or non-volitional flow of a body fluid through a body lumen, modify the size or shape of a body lumen or cavity, treat prostate enlargement, treat urinary incontinence, support or maintain positioning of a tissue, organ or graft, perform a cosmetic lifting or repositioning procedure, form anastomotic connections, and/or treat various other disorders where a natural or pathologic tissue or organ is pressing on or interfering with an adjacent anatomical structure. Also, the invention has a myriad of other potential surgical, therapeutic, cosmetic or reconstructive applications, such as where a tissue, organ, graft or other material requires retracting, lifting, repositioning, compression or support.
  • In one or more embodiments, the disclosed device can have a compact shaft profile which, for example, can fit into a 19 F cystoscopic sheath for patient tolerant access during an awake procedure. The device has a stiff distal shaft to allow manual compression of tissue at an interventional site by means of leveraging the tool handle. In a specific application, a spring-driven needle can be deployed to a single depth, and sized to pierce through a predominate population of urethral-prostatic distances. An automated deployment of the needle through anatomy is contemplated to pierce reliably with sufficient force and speed. Moreover, the device can be provided with structure providing manual retraction of the needle to provide tactile feedback to the user to confirm completion of needle retraction. This also simplifies the mechanics to provide the option to retract the needle at any time and results in depositing the first and second anchor components in the tissue after needle refraction.
  • Further, the device can be configured with suture guides which provide centering of the suture and/or a stop to hold the suture stable while an anchor is placed on it to ensure a reliable assembly of an anchor assembly. Additionally, an automated tensioning spring is provided for actuation during the lever retraction, thus providing consistent suture tension during the anchor deployment and making the anchor seating more reliable, as well as minimizing the distance between the two anchors and holding the target tissue approximated. Also, a delivery tool shaft lumen that has at least one flat registration surface to align the anchors to be registered with the tensioned suture as well as a spring-like obstructive tab are used to maintain the most distal anchor in position prior to deployment. Actuation of a final trigger can then translate a pusher element to advance the anchor onto the suture with sufficient speed and force to seat with reliable retention force.
  • Other features and advantages of the present invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the principles of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a left side view, depicting one embodiment of an anchor delivery system;
  • FIG. 2 is a perspective view, depicting the anchor delivery system of FIG. 1;
  • FIG. 3 is a right side view, depicting the anchor delivery system of FIG. 1;
  • FIG. 4 is a side view, depicting the anchor delivery system of FIG. 3 with a portion of the casing removed;
  • FIG. 5 is a left side view, depicting the anchor delivery device of FIG. 1 with a portion of the casing removed;
  • FIG. 6 is an exploded view, depicting the device of FIG. 1;
  • FIG. 7 is a perspective view, depicting a needle drive spool assembly;
  • FIG. 8 is another perspective view, depicting the needle drive spool assembly of FIG. 7;
  • FIG. 9 is an exploded view, depicting the needle drive spool assembly of FIG. 7;
  • FIG. 10 is an enlarged view, depicting a portion of the needle drive spool assembly;
  • FIG. 11 is an enlarged view, depicting a portion of the needle assembly attached to the needle drive spool assembly;
  • FIG. 12 is a perspective view, depicting a cartridge assembly of the delivery device;
  • FIG. 13 is a rotated perspective view, depicting the cartridge assembly of FIG. 12;
  • FIG. 14 is an exploded view, depicting components of the cartridge assembly;
  • FIG. 15 is a side view, depicting a first component of an anchor and anchoring delivery system;
  • FIG. 16 is a perspective view, depicting components for attaching components of FIG. 15 to a cartridge assembly;
  • FIG. 17 is a perspective view, depicting replacing a cartridge assembly within an anchor delivery device;
  • FIG. 18 is a perspective view, depicting attachment of a cartridge assembly to other components of anchor delivery system;
  • FIG. 19 is a perspective view, depicting loading a portion of an anchor assembly emerging from a cartridge to pass through a needle assembly within a delivery device;
  • FIG. 20 is a perspective view, depicting a further step involving loading of a cartridge assembly;
  • FIG. 21 is a perspective view, depicting yet another step in loading of a cartridge assembly involving advancing a portion of the anchor assembly to a distal end of the delivery device;
  • FIG. 22 is a cross-sectional view, depicting a first step involving an interventional procedure;
  • FIG. 23 is a partial cross-sectional view, depicting a delivery device in a non-actuated configuration;
  • FIG. 24 is a perspective view partially in cross-section, depicting a distal terminal end of a delivery device;
  • FIG. 25 is a partial cross-sectional view, depicting depression of an actuator of a delivery device;
  • FIG. 26 is a partial cross-sectional view, depicting disengagement of an actuator of a delivery device;
  • FIG. 27 is a perspective view in partial cross-section, depicting partial ejection of a needle assembly;
  • FIG. 28 is a perspective view in partial cross-section depicting complete ejection of a needle assembly ejection;
  • FIG. 29 is a cross-sectional view, depicting advancement of a needle assembly at an interventional site;
  • FIG. 30 is a partial cross-sectional view, depicting a delivery device in a ready state;
  • FIG. 31 is a partial cross-sectional view, depicting depression of an actuator of a delivery device;
  • FIG. 32 is a partial cross-sectional view, depicting action of components of a delivery device upon depression of an actuator;
  • FIG. 33 is a partial cross-sectional view, depicting complete depression of a lever of a delivery system;
  • FIG. 34 is a perspective partial cross-sectional view, depicting withdrawal of a needle assembly leaving a connector element;
  • FIG. 35 is a cross-sectional view, depicting delivery of a first component of an anchor assembly at an interventional site;
  • FIG. 36 is a partial cross-sectional view, depicting positional relationships of internal components of the delivery system upon actuation of an actuator;
  • FIG. 37 is a partial cross-sectional view, depicting further action of internal components of the delivery device;
  • FIG. 38 is a partial cross-sectional view, depicting yet further action of internal components of the delivery device;
  • FIG. 39 is a side view, depicting components of a needle drive spool assembly;
  • FIG. 40 is a cross-sectional view, depicting components of a needle drive spool assembly;
  • FIG. 41 is a side view, depicting action of components of a spool assembly;
  • FIG. 42 is a cross-sectional view, depicting the structure of FIG. 41 after actuation;
  • FIG. 43 is a perspective view, depicting components of a cartridge assembly in conjunction with components of a needle drive assembly;
  • FIG. 44 is a perspective view, depicting the components of FIG. 43 subsequent to action of an actuator;
  • FIG. 45 is a perspective view, depicting further action of the components of FIG. 43 subsequent to action of a retraction lever;
  • FIG. 46 is a perspective view, depicting yet further action of the components of FIG. 43;
  • FIG. 47 is a perspective view, depicting a shaft assembly of the delivery device;
  • FIG. 48 is a perspective view, depicting structure defining a scope mount;
  • FIG. 49 is a perspective view and partial cross-sectional view, depicting a sheath mount assembly;
  • FIG. 50 is a perspective view, depicting a cutter assembly of the delivery device;
  • FIG. 51 is a perspective view, depicting a terminal end of the cutter assembly of FIG. 50;
  • FIG. 52 is a perspective view, depicting a pusher assembly of the delivery device;
  • FIG. 53 is a perspective view, depicting a trigger assembly of the delivery device;
  • FIG. 54 is an exploded view, depicting the components of the trigger assembly of FIG. 53;
  • FIG. 55 is a partial cross-sectional view, depicting the delivery device prior to depression of the retraction lever;
  • FIG. 56 is a partial cross-sectional view, depicting the device of FIG. 55 after depression of the retraction lever;
  • FIG. 57 is a partial cross-sectional view, depicting further action of components of the device depicted in FIG. 56;
  • FIG. 58 is a partial cross-sectional (inferior) view, depicting action of the trigger assembly;
  • FIG. 59 is a partial cross-sectional view, depicting a delivery device readied for depression of the proximal anchor actuator;
  • FIG. 60 is a partial cross-sectional view, depicting a depression of the proximal anchor actuator of the device shown in FIG. 59;
  • FIG. 61 is a partial cross-sectional view, depicting action of internal components of a delivery device after depression of the proximal anchor actuator;
  • FIG. 62 is a perspective view, depicting advancement of a second anchor component into engagement with a connector;
  • FIG. 63 is a cross-sectional view, depicting release of a second anchor component within an interventional site;
  • FIG. 64 is a partial cross-sectional view, depicting yet further action of components internal to the delivery device;
  • FIG. 65 is a perspective view, depicting cutting of a connector;
  • FIG. 66 is a cross-sectional view, depicting release of an assembled anchor assembly within an interventional site;
  • FIG. 67 is a cross-sectional view, depicting an untreated interventional site;
  • FIG. 68 is a cross-sectional view, depicting implantation of two anchor assemblies at an interventional site; and
  • FIG. 69 is an enlarged view of a portion of FIG. 68.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Turning now to the figures, which are provided by way of example and not limitation, the present disclosure is directed to a device configured to deliver anchor assemblies within a patient's body. As stated, the disclosed apparatus can be employed for various medical purposes including but not limited to retracting, lifting, compressing, approximating, supporting or repositioning tissues, organs, anatomical structures, grafts or other material found within a patient's body. Such tissue manipulation is intended to facilitate the treatment of diseases or disorders. Moreover, the disclosed invention has applications in cosmetic or reconstruction purposes or in areas relating the development or research of medical treatments.
  • In one particular aspect, the anchor assembly of the present disclosure is contemplated to be formed of a structure which is visible by ultrasound. Accordingly, the anchor assembly can be viewed during ultrasonic body scans such as during normal trans-rectal ultrasound when a medical professional is conducting diagnoses or treatment associated with conditions like prostate cancer.
  • In an aspect of the present invention, one portion of an anchor assembly or implant is positioned and implanted against a first section of anatomy. A second portion of the anchor assembly or implant is then positioned and implanted adjacent a second section of anatomy for the purpose of retracting, lifting, compressing, approximating, supporting or repositioning the second section of anatomy with respect to the first section of anatomy as well as for the purpose of retracting, lifting, compressing, approximating, supporting or repositioning the first section of anatomy with respect to the second section of anatomy. It is also to be recognized that both a first and second portion of the anchor assembly can be configured to accomplish the desired retracting, lifting, compressing, approximating, supporting or repositioning of anatomy due to tension supplied thereto via a connector assembly affixed to the first and second portions of the anchor assembly or implant.
  • Referring now to FIGS. 1-3, there is shown one embodiment of a device 100. This device is configured to include structure that is capable of both gaining access to an interventional site as well as assembling and implanting one or more anchor assemblies or implants within a patient's body. In one aspect, the device 100 is configured to assemble and implant a single anchor assembly or implant with a replaceable cartridge. If the user replaces the cartridge another anchor assembly or implant can be assembled and implanted. The device is further contemplated to be compatible for use with a 19 F sheath. The device additionally includes structure configured to receive a conventional remote viewing device (e.g., an endoscope) so that the steps being performed at the interventional site can be observed.
  • The anchor delivery device 100 includes a handle assembly 102 connected to an elongate tissue access assembly 104. The elongate tissue access assembly 104 houses components employed to construct an anchor assembly and is sized to fit into a 19 F cystosopic sheath for patient tolerance during a procedure in which the patient is awake rather than under general anesthesia. The tissue access assembly is stiff to allow manual compression of tissue at an interventional site by leveraging the handle assembly 102.
  • The anchor delivery device 100 further includes a number of subassemblies. A handle case assembly 106 including mating handle parts encase the handle assembly 102. The handle assembly 102 is sized and shaped to fit comfortably within an operator's hand and can be formed from conventional materials. Windows can be formed in the handle case assembly 106 to provide access to internal mechanisms of the device so that a manual override is available to the operator in the event the interventional procedure needs to be abandoned.
  • In one embodiment, the delivery device 100 is equipped with various activatable members which facilitate assembly and delivery of an anchor assembly at an interventional site. A needle actuator 108 is provided and as described in detail below, effectuates the advancement of a needle assembly (loaded with a first component of an anchor assembly) to an interventional site. In a preferred embodiment, the needle assembly has a needle that moves through a curved trajectory and exits the needle assembly in alignment with the handle element, in particular embodiments, in alignment with the grip. In various other embodiments, the needle housing is oriented such that the needles exits the housing at either the two o'clock or ten o'clock positions relative to a handle grip that is vertical. A needle retraction lever assembly 110 is also provided and when actuated causes the needle assembly to be withdrawn and expose the first anchor component. This action and the structure involved is also described in detail below. Finally, the delivery device 100 is equipped with a rear or proximal anchor actuator assembly 112 which as fully described below, upon actuation, accomplishes assembly of a second component to the anchor assembly and release of the anchor assembly at the interventional site.
  • Turning now to FIGS. 4-6, a number of the subassemblies of the delivery device 100 are introduced, the function and structure of each of which are addressed in detail below. In the embodiment depicted, the case assembly 106 has three mating parts, a left top case 114, a left bottom case 116, and a right case 118. It is within the scope of the present invention that the case assembly be made of a variety of numbers of parts. In addition to mating to enclose subassemblies, the case parts also include structural features for providing rigidity and support for the enclosed components.
  • Housed within the case assembly 106 are a needle retract spool assembly 120 and a cartridge assembly 122. The rotational axes of the needle spool assembly and cartridge assembly are the same. A shaft assembly 124 includes a portion residing within the case assembly 106 and a portion extending from a forward end of the case assembly. Attached to and operatively associated with the shaft assembly 124 is a trigger assembly 126. The trigger assembly 126 is also housed within the case assembly 106. FIGS. 4 and 5 illustrate the juxtapositional relationships of the various subassemblies and FIG. 6 is an exploded view depicting the subassemblies.
  • With reference to FIGS. 7-9, details concerning this embodiment of the structure of the needle spool assembly 120 are presented. As described further below, the needle retract spool assembly 120 cooperates with the needle actuator and needle retraction lever to advance and then withdraw a needle assembly at an interventional site.
  • The needle retract spool assembly 120 is a compact structure including a number of moving pieces. A needle spring housing 202 forms one side of the assembly 120 and is placed adjacent to a needle spool housing 204. An outer side of the needle spring housing 202 forms a generally flat surface and formed on the opposite side of the needle spring housing 202 is a circular recess. When the needle retract spool assembly 120 is in its assembled form, the circular recess of the needle spring housing 202 faces the needle spool housing 204. Formed in opposite sides of the needle spool housing 204 are two additional generally circular recesses.
  • Between the needle spring housing 202 and the needle spool housing 204 and within the facing circular recesses formed therein, are a needle deploy spring 206 configured within and adjacent a needle deploy spring arbor 208, which is adjacent to a needle clutch plate 210. The needle clutch plate 210, in turn, is adjacent and received within a circular recess formed in a needle clutch cup 212. Received in the needle spool housing 204 recess opposite of the needle spring housing 202 is a needle spool 214. The needle deploy spring 206 functions to rotate the needle spool 214 and to project a tip of the needle through tissue with force and speed. In one approach, it is contemplated that the device 100 be configured so that the needle is deployed to a single depth to pierce through a predominant population of urethral-prostatic distances.
  • Each of the generally circular profiled needle deploy spring 206 and needle deploy spring arbor 208 include a center through hole. Further, a clutch push rod 216 extends through such aligned holes of a completed assembly from the outer side of the needle spring housing 202 and through the needle deploy spring 206 and needle deploy spring arbor 208. A pivotable clutch actuator 218 configured on the outside surface of the needle spring housing 202, as described in further detail below through its interaction with the needle retraction lever, causes lateral movement of the push rod 216 so that it engages the needle clutch plate 210 separating it from the spring arbor 208. The spring arbor 206 is rotationally biased by the needle deploy spring 206, which can be formed of a helically arranged motor spring. A needle spring reset lever 220 is further provided, the same being accessible to reset the spring arbor 208 after an initial use.
  • As stated, the clutch plate 210 is received within the needle clutch cup 212. The interior of the clutch cup 212 includes bosses (not shown) sized to mate with corresponding recesses formed in the clutch plate 210. Further, a center hole formed in the clutch plate 210 is sized to receive a center post extending from an adjacent face of the clutch plate. Such structure facilitates complementary rotation of the clutch plate 210 and clutch cup 212. Complementary rotational motion of the clutch cup 212 and the needle spool 214 is also accomplished through an interconnection of these pieces through a center hole form in the needle spool housing 204.
  • The assembly further includes a needle deploy pawl 222 which is operatively associated with the needle actuator. As shown and described below, the needle actuator pivots the needle deploy pawl 222 away from engagement with the spring arbor 208, thereby permitting rotation of the same.
  • An unsheathing pawl 224 is also provided and configured at one end to engage the needle retraction lever. At another end of the unsheathing pawl 224 there is structure configured to engage a capsular cartridge spool (described below) to thereby fix its rotational position while the needle spool 214 rotates.
  • As shown in FIGS. 10 and 11, a proximal end 230 of a needle assembly can be sized and shaped for connecting with other structure. In one approach, the proximal end of the needle assembly includes a shoulder sized and shaped for receipt within a corresponding recess formed near a periphery of the needle spool 214. Other approaches to effecting a connection are also contemplated such as using a shear wire (not shown) to engage a recess formed in the end of the needle assembly and hold the needle assembly in place relative to the needle spool. Through such connections, rotation of the needle spool 214 can result in advancing and withdrawing lengths of a needle assembly. In this regard, as shown in FIGS. 10-11, a peripheral recess formed in the needle spool 214 is provided to take up lengths of a needle assembly.
  • Details of the cartridge assembly 122 are depicted in FIGS. 12-14. A generally circular profiled suture spool sleeve 302 forms an outer structure of the cartridge assembly 122. Between a generally disk shaped suture spool track 304 and a primary knob 306 and within the suture spool sleeve of an assembled cartridge 122, are a tensioning spring 308 and a suture spool 310. As is developed below, the tensioning spring 300 functions to provide a tension on a connector member (e.g., a suture) of an anchor assembly. Various different cartridges can be provided which embody springs having varying tensions associated therewith. Moreover, the system can be configured to provide a different tension when advancing the connector member from that generated subsequent to placement of the anchor assembly at an interventional site. The suture spool 310 is configured to releasably engage the unsheathing pawl 224. Also provided, the function of which is described below, are a knob follower 312 and wire clip 314.
  • One form of a distal anchor 350 and connector member 352 of an anchor assembly is shown in FIG. 15. At a proximal end of the anchor assembly there can be configured a pusher (e.g., a PTFE coated stainless steel wire) 354 attached to the connector member 352 (e.g., a PET monofilament suture) by a sleeve (e.g., polyimide sleeve) 356. It is a proximal terminal end of the pusher 354 which is fixed to the suture spool 304 by the wire clip 314 (See FIG. 16). An annular space formed about the suture spool 304 is provided to receive a length of the pusher 354.
  • Referring now to FIGS. 17-21, a particular advantage of this embodiment is that the cartridge assembly 122 is removable and replaceable. In the preferred embodiment, a door on the case can be opened or an open window can be in the case to provide access to the interior of the delivery device. Alternatively, the left top case 114 can be removed providing access to an interior of the delivery device. When replacing, the cartridge assembly 122 can be placed within an outside recess of the spool housing 204 and into engagement with the needle spool 214. The center post extending from the needle spool 214 helps guide the cartridge assembly 122 perpendicularly to the needle spool 214. Shoulders 360, 362 formed on the needle spool 214 and the cartridge assembly 122, respectively, ensure proper alignment between the pieces. As shown best in FIG. 19, a leading terminal end 364 of an anchor assembly protrudes from a cartridge shoulder 362, a length of the assembly previously being configured about the suture spool. The terminal end 364 of the assembly aligns with and is insertable within a hole 366 formed in a shoulder 360 of the needle spool.
  • Once inserted, the primary knob 306 of the cartridge assembly 122 is rotated (FIGS. 20-21) to advance the leading terminal end and connector portion of the anchor assembly through the hole 366 then through the length of the needle assembly (See FIGS. 10-11). The primary knob 306 is continued to be rotated until the knob follower 312 registers at a completion point to thereby signal that the anchor assembly is fully loaded within the needle assembly and in one embodiment the leading end of the anchor assembly is just proximal the distal opening of the needle.
  • In one particular, non-limiting use in treating a prostate (See FIG. 22), the elongate tissue access portion 104 of a delivery device is placed within a urethra (UT) leading to a urinary bladder (UB) of a patient. The elongate portion 104 is advanced within the patient until a leading end 400 thereof reaches a prostate gland (PG).
  • As shown in FIG. 23, the delivery device 100 is at this stage configured in a ready state. The needle actuator 108 and the needle retracting lever 110 are in an inactivated position. The needle actuator 108 is spring biased by a rotating biasing assembly 402. A needle actuator safety (not shown) can be included to lock the needle trigger 108 in an inactive position. Upon depression of the needle actuator 108, a lock-out cam assembly 404 is rotated ninety degrees thereby permitting subsequent actuation of the needle retracting lever 110. The assembly further includes a lever lock 406 configured to hold the depressed needle retracting lever after retraction of the lever 110. It is at this stage also that the terminal end 400 of the elongate portion 104 of the delivery device houses a completely withdrawn needle assembly 410 and further includes a second anchor assembly component 450 registered for later deployment (See FIG. 24).
  • Initial depression of the needle actuator 108 causes components of the biasing assembly 402 to pivot (See FIG. 25). Releasing the needle actuator 108 facilitates it returning to an undepressed condition and permits the lock-out cam assembly 404 to rotate ninety degrees (See FIG. 26). In this position, the lock-out cam assembly 404 is positioned to permit actuation of the needle retraction lever 110.
  • At the leading end 400 of the delivery device, as shown in FIGS. 27 and 28, such action results in the needle assembly being advanced from within the elongate member 104. As is to be appreciated, the needle is ejected by the needle deploy spring 206 in this embodiment in a direction commensurate with the direction the handle assembly extends. Moreover, the needle assembly can be configured so that it curves back toward the handle as it is ejected. In use in a prostate intervention (See FIG. 29), the needle assembly 410 is advanced through and beyond a prostate gland (PG). The spring deployment helps to ensure the needle tip passes swiftly through the tough outer capsule of the prostate without “tenting” the capsule or failing to pierce the capsule. In an alternate embodiment, the needle could be manually deployed by the user. In one approach, the needle 410 is made from Nitinol tubing and can be coated with Parylene N. Such a coating helps compensate for frictional or environmental losses (i.e. wetness) which may degrade effectiveness of needle penetration.
  • Referring to FIGS. 30-32, the actions of internal sub-components of the delivery device 100 upon actuation of the needle actuator 108 are described. FIG. 30 shows the needle actuator 108 in an unactuated state. As the needle actuator 108 is depressed (FIG. 31), it rotates and an extension thereof engages the needle deploy pawl 222. Continual depression of the needle actuator (FIG. 32) causes the needle pawl 222 to rotate from its engagement with the needle deploy spring arbor 208. This disengagement then permits the needle deploy spring 206 to rotate the needle deploy arbor 208, clutch plate 210, needle clutch cup 212 and needle spool 214 (See FIG. 9). Rotational motion of the needle deploy spring arbor 208 can be observed by noting the change in position of the needle spring reset lever 220. Again, through its connection with a needle assembly, rotation of the needle spool 214 causes the needle assembly to be advanced a desired distance.
  • Next, after complete depression of the needle actuator 108 and the unlocking of the needle retraction lever 110, the needle retraction lever 110 can be completely actuated (See FIG. 33). When so actuated, the lever lock 406 engages and locks the lever 110 in place. The lever lock 406 can be later manipulated to unlock the lever 110. Such action results in a withdrawal of the needle assembly 410, leaving the connector 352 of an anchor assembly in an extended position (See FIG. 34). When extended, the connector 352 extends through the needle window and is centered by suture guide structure. As shown in FIG. 35, in a prostatic interventional procedure, the same results in configuring a first or distal anchor component beyond an outer surface of a prostate gland (PG) with the connector 352 extending toward the terminal end 400 of a delivery device.
  • Internal to the delivery device 100, actuation of the needle retraction lever 110 causes the rotation of the pivotable clutch actuator 218 (See FIGS. 31-38). As shown in FIG. 36, the clutch actuator 218 is in a home position. Upon actuation of the lever 110, the clutch actuator 218 rotates (See FIG. 37).
  • As best seen in FIGS. 39-42, rotation of the pivotable clutch actuator causes an inclined lever surface thereof to engage the push rod 216. This in turn causes lateral translation of the push rod 216 against the clutch plate 210 as well as a disengagement thereof from the spring arbor 208. This disengagement consequently results in configuring needle spool 214 to allow manual retraction of the needle assembly by manipulating the needle retraction lever 110 and to provide a tension on a connector of an anchor assembly. Manual retraction of the needle provides a simplified approach as well as tactile feedback to the operator to confirm completion of needle retraction. It is to be recognized that such unclutching of the needle deploy spring allows manipulation of the needle retraction lever 110 to be tolerable by the patient and with little to no delivery device tool movement. The tensioning spring 308 provides the tension forces which helps to ensure the distal anchor is pulled back into firm contact with a desired tissue plane such as, for example, the outer capsular surface of the prostate gland. Notably, the spring in a preferred embodiment provides a desired force such as up to 1-2 pounds or more of tension. In another embodiment, a spring can be used to automatically retract the needle assembly.
  • The timing of the needle retraction and tensioning is accomplished through the interaction of the unsheathing pawl 224 and the needle spool 214. As shown in FIGS. 43 and 44, the unsheathing pawl 224 is configured to permit a clockwise rotation of the needle spool which occurs during needle actuator depression until the unsheathing pawl 224 registers within grooves formed in the needle spool. Actuation of the needle retraction lever 110 causes a deflection of the unsheathing pawl 224 (See also FIG. 38) which disengages the unsheathing pawl 224 from the needle spool 214. Since the needle spool 214 is at this point disengaged from the operation of the spring arbor as described above, the needle spool 214 is permitted to rotate in a counterclockwise direction as illustrated in FIG. 46. This counterclockwise rotation continues until the unsheathing pawl 224 again registers in recesses 516 formed in the needle spool 214 (FIG. 46). Such recesses can be spaced to provide desired corresponding needle depths. Also, this structure can be equipped with a roller-clutch (not shown) which would provide a continuous process of longitudinal movement. The tensioning spring of the cartridge assembly 122 (See FIG. 14) is then left to automatically provide a consistent tensioning force on a connector of an anchor assembly. It is at this juncture that the connector gets pulled into suture guide structure 411 (see FIG. 34) to center the connector and ready it for engagement with a second anchor component. Such tensioning results in seating a distal or first anchor component 350 as desired within an interventional site such as shown in FIG. 35 as well as to minimize a distance between two anchor members of an implanted anchor assembly. Again, the tension generated after seating the anchor component 350 can be different from that during delivery of the connector of the anchor assembly.
  • A more detailed description of the shaft assembly and trigger assembly now follow as does a description of the operation of the trigger assembly to achieve assembly of a second or proximal anchor component to a connector of an anchor assembly and release of a complete anchor assembly at the interventional site.
  • With reference to FIG. 47, there is shown an embodiment of a shaft assembly 124. As previously disclosed, a trigger assembly (described below) is mounted to the shaft assembly 124 and the shaft assembly 124 includes components residing within the device case assembly 106 as well as structure extending therefrom. A terminal end portion 400 of the shaft assembly 124 includes an atraumatic tip sleeve 502. Proximally located to the tip sleeve 502 is a tubular shaft assembly 504 which is sized and shaped to slidably receive the needle assembly. A distal end portion of the tubular shaft assembly 504 is curved so that a needle projecting therefrom extends in a direction generally corresponding to that of the handle of the delivery device. Configured longitudinally adjacent the tubular shaft assembly is a scope tube 506 which is sized and shaped to receive a scope. Configured below and longitudinally adjacent the scope tube 506 is an elongate cover 507 which is sized to receive elongate portions of the cutter and pusher assemblies.
  • At a proximal end of the shaft assembly 124 is a scope mount lock screw assembly 508. A sheath mount assembly 510 including a screw lock 512 is spaced distal and longitudinally from the scope mount assembly 508. Configured between these assemblies are components of a cutter assembly 514 and a pusher assembly 516. It is to be recognized, however, that both the cutter and pusher assemblies include elongate portions extending toward a distal end 400 of the shaft assembly 124.
  • As shown in FIG. 48, the scope mount lock screw assembly 508 includes a screw lock 520 rotatably positioned adjacent a scope mount receiver 522. The scope mount assembly further includes a handle pusher support snap fit 524. As best seen in previously presented FIGS. 3-5, the scope mount lockingly engages a scope 550 which has a longitudinal dimension sufficient to extend longitudinally substantially a length of the scope tube 506.
  • The sheath mount 510 can be screwed to elongate portions of the shaft assembly (See FIG. 49). The sheath mount 510 can include a seal 530 which functions to seal and minimize fluid ingress into the handle portion of a delivery device.
  • As best shown in FIGS. 50 and 51, an embodiment of the cutter assembly 514 includes a cutter plate 560 supporting a distally directed, elongate cutter tube 562 and a guide 564. A pair of spring extensions 566 are also provided and are each configured to be attached to a cutter spring. A distal end 568 of the cutter tube 562 is configured with a blade so that once cutter springs are permitted to withdraw the cutter assembly 514, the blade can sever as desired a connector of an anchor assembly.
  • With reference to FIG. 52, an embodiment of the pusher assembly 516 of the shaft assembly 124 is described. The pusher assembly 516 includes an elongate pusher member 580 extending from a pusher block 582 to a pusher extension 584. As described in more detail below, the pusher extension 584 engages a proximal end of a second or proximal anchor component. The pusher block 582 further includes a plurality of recesses 586 sized and shaped to receive corresponding structure of the trigger assembly.
  • Details of an embodiment of the trigger assembly 126 are depicted in FIGS. 53 and 54. The assembly 126 includes a base 602 and a frame 604 to which other components are affixed or supported. A lever pivot 606 is rotatably attached to a proximal anchor actuator assembly 608. As described below, the lever pivot 606 is rotated through action of the lever from a first position where it locks the rear or proximal anchor actuator 608 against actuation to a second position where actuation of the proximal anchor actuator is possible. Eventual actuation of the proximal anchor actuator assembly 608 causes a deflection of a trigger 610 which releases a tripper 612 having cammed surfaces. A first pawl 614 is further provided and placed against both the camming surfaces of the tripper 612 and into recesses formed in the pusher block of the above disclosed pusher assembly. As described below, a second pawl 616 follows the action of the first pawl 614 to engage as desired the pusher block. A cutter pawl 618 is also placed into engagement with camming surfaces of the tripper 612, the cutter pawl cooperating to actuate the cutter assembly. Furthermore, the trigger assembly 126 also includes a reset lever 620 and a cutter bailout assembly 622 including a biasing spring 624, operation of which will be described below. It is to be recognized, however, that the system can be configured such that manipulation of the needle retract lever, for example, can accomplish resetting the device as well as the bailout function.
  • With reference now to FIGS. 55-58, an embodiment of the anchor delivery is shown in cross-section to illustrate locked and unlocked configurations of the trigger assembly 126. In FIG. 55, the needle actuator 108 and needle refractor lever 110 are in a non-actuated position and the lever pivot 606 is in a first position locking the button pad assembly 608 against actuation. Upon depression of the needle actuator 108 and subsequent actuation of the retraction lever 110 (See FIG. 56), the lever pivot 606 is rotated out of engagement with the proximal anchor actuator assembly 608. It is at this stage that the proximal anchor actuator 608 is unlocked and can be depressed (See FIG. 57). Once depressed, the proximal anchor actuator assembly 608 translates longitudinally to rotate the trigger 610 out of locking engagement with the tripper 612. This, in turn, initiates the action of the trigger assembly 126.
  • Turning now to FIG. 59, the trigger assembly 126 is shown prior to actuation. As shown, the proximal anchor actuator 608 is readied for depression and the trigger 612 is in its longitudinally distal position. Also, the first pawl 614 is in a first position in locking engagement with the pusher 582 of the pusher assembly (See Also FIG. 58).
  • Pressing the proximal anchor actuator assembly 608, as above stated, releases the tripper 612. Being biased by a spring assembly 650, upon release the tripper 612 moves proximally relative to an operator (See FIG. 60). As it moves proximally, camming surfaces on the tripper 612 rotate the first pawl out of engagement with the pusher 582. This action results in the release of the pusher assembly (See also FIG. 52) to move longitudinally in the distal direction. Control of the longitudinal translation of the pusher assembly is maintained by the second pawl 616 which follows movement of the first pawl, and which rotates to again lock the pusher 662.
  • Accordingly, release of the pusher assembly accomplishes advancing the pusher thereof distally resulting in advancing a second component 450 of an anchor assembly into locking engagement with a connector of an anchor assembly (See FIG. 62). Such action causes the pusher 582 to advance an anchor component 450 onto a connector (e.g., a suture) with sufficient speed and force to seat the anchor 450 with reliable retention force. Within a patient's body, as shown in FIG. 63, the anchor assembly is configured across anatomy within the interventional site. Longitudinally displaced cutter cam surfaces formed on the tripper 612 then subsequently engage the cutter pawl 618 to rotate it out of engagement with the cutter assembly (See FIGS. 50-55) to thereby allow it to be withdrawn by action of springs 660 biasing the cutter assembly (See FIG. 64). Upon withdrawal of the cutter assembly, the blade portion 570 (See FIGS. 51 and 65) thereof is brought across the connector 352 thereby severing it close to the second anchor component 450. The resultant implanted anchor assembly 700 is shown in FIGS. 65, 68 and 69. FIG. 68 depicts a partial cross-sectional view of the urethra (UT) widened due to the anchor assembly compressing the surrounding enlarged prostate tissue due to the fact that the outer capsular tissue is rather strong, non-compressible and non-displaceable and the adenoma of the prostate gland and the urethral wall are compressible and displaceable. By way of comparison, FIG. 67 depicts a partial cross-sectional view of an untreated interventional site of the urethra (UT) narrowed by the surrounding enlarged prostate tissue.
  • As shown in FIGS. 62 and 65, the delivery device 100 can be configured to retain and deploy multiple second anchor components 450. The anchor components 450 are placed in-line and arranged such that a single anchor component is advanced one deployed anchor length with each trigger actuation. Upon reset of the trigger assembly a next sequential anchor component is readied for deployment. In this regard, the cover 507 can be configured with a spring-like distal tab 710 which engages a slot formed in the second to most distally positioned anchor component and which facilitates maintaining proper positioning of the most distal anchor prior to deployment. The cover 507 can further be equipped with a proximal suture slot (not shown) and include an interior arranged to include at least one flat registration surface to align anchor components 450 with connector members 352 (See FIG. 62). Furthermore, the distal end of the delivery device can be equipped with a flexible/elastomer cover. This cover shields the anchor deployment space to ensure reliable anchor seating on connector and to allow for ejection of an implant from a delivery tool. In FIG. 65, the distal end of the delivery device is shown within cystoscopic sheath 712.
  • The second anchor component can be embodied in a slotted anchor configured to secure to a connector. The slotted proximal anchor can include a flattened-tubular back end that resembles a flattened tube in shape, with a width in lateral cross-section that is greater than its thickness. The slotted proximal anchor also includes a pair of spaced apart prongs extending from the back end of the slotted proximal anchor to the front end of the slotted proximal anchor. The spaced prongs join together at a slot inception. The prongs are shaped and sized of a configuration and of a rigidity to substantially prevent deflection of the prongs. The prongs can include inwardly facing protrusions that are configured to capture and deform the connector between the protrusions and prevent the connector from disengaging from the slotted anchor device once engaged. The mechanism of suture attachment and strength of the assembly is a combination of compression of the suture between the stiff slotted prongs of the anchor as well as disruption of the suture surface by the discreet edges of the slotted, flattened-tubular anchor. The discreet edges provide a lower contact surface area between anchor prongs and suture and focuses the compressive forces in focal points that cause the suture to conform around both internal recesses and external faces. It is also to be recognized that various further embodiments of slotted anchors or anchors forming a clip are also contemplated. In particular, various embodiments of structures which accordingly provide alternative approaches to attach to a connector can be employed. That is, the anchors can be deformable, deflectable, latching, nested, meltable and/or coiled in structure.
  • Accordingly, the present invention contemplates both pushing directly on anchor portions of an anchor assembly as well as pushing directly upon the connector of the anchor assembly. Moreover, as presented above, the distal or first anchor component is advanced and deployed through a needle assembly and at least one component of the proximal or second anchor component is advanced and deployed from a housing portion of the anchor deployment device. Further, both a single anchor assembly or multiple anchor assemblies can be delivered and deployed at an intervention site by the deployment device. Consequently, in the context of prostate treatment, the present invention is used for the compression of the prostate gland and the opening of the prostatic urethra, the delivering of an implant at the interventional site, and applying tension between ends of the implant. Moreover, drug delivery is both contemplated and described as a further remedy in BPH and over active bladder treatment as well as treating prostate cancer and prostatitis.
  • Once implanted, the anchor assembly of the present invention accomplishes desired tissue manipulation, compression or retraction as well as cooperates with the target anatomy to provide an atraumatic support structure. In one preferred embodiment, the shape and contour of the anchor assembly 700 is configured so that the assembly invaginates within target tissue, such as within natural folds formed in the urethra by the opening of the urethra lumen by the anchor assembly (See FIGS. 68-69). In fact, in situations where the anchor assembly is properly placed, wispy or pillowy tissue in the area collapses around the anchor structure. Eventually, the natural tissue can grow over the anchor assembly 700 and new cell growth occurs over time (see FIG. 69). Such cooperation with target tissue facilitates healing and avoids unwanted side effects such as calcification or infection at the interventional site.
  • The disclosed anchor delivery device can be configured for multiple or single use. In this regard, multiple or a single first anchor component can be loaded within the delivery device via a cartridge assembly, which is a removable and replaceable assembly. Further, multiple or a single second anchor component can be configured within the shaft assembly such as shown in FIG. 34. In this regard, the second anchor components can be lined up end to end within the shaft assembly with a proximal most second anchor component being placed into engagement with a lead end of the pusher assembly.
  • Additionally, after a first use, the spool assembly of the delivery device can be reset for further use through the manipulating of the reset lever 220 (See FIGS. 30-32, 36-38). An initial step in resetting the device would involve releasing the needle retraction lever 110 from its engagement with the locking mechanism 406 (See FIG. 33). Further, the trigger assembly can be reset through the actuator of the trigger reset lever 620.
  • It has also been observed that in certain situations there may be a need for a cutter bailout assembly 622 (See FIGS. 54, 58 and 59) after the first anchor component has been delivered within an interventional site (FIG. 35). Depression of the cutter bailout assembly 622, when needed, results in tripping the cutter pawl thereby releasing the cutter assembly and subsequently cutting a connector of an anchor assembly prior to completing assembly of the anchor. It is contemplated within the present invention the ability to retract the needle at any time including arresting a moving needle and retracting an incompletely deployed needle.
  • Furthermore, in addition to an intention to cooperate with natural tissue anatomy, the present invention also contemplates approaches to accelerate healing or induce scarring. Manners in which healing can be promoted can include employing abrasive materials, textured connectors, biologics and drugs.
  • It has been observed that placing the anchors at various desired positions within anatomy can extract the best results. For example, when treating a prostate, one portion of an anchor assembly can be placed within an urethra and a second component beyond the outer surface of the prostate. It has been found that implanting the anchor assemblies by using the distal end of the device to displace the prostate lobe on either side (while the tension spring is taking up slack in the connector after the delivery needle has been refracted) while deploying the second anchor component so that the ten o'clock and two o'clock positions (when looking along the axis of the urethra) are supported or retained, effectively holds the anatomy open and also facilitates invagination of the anchor portion within natural tissue. This is particularly true in the regions of anatomy near the bladder and the juncture at which the ejaculatory duct connects to the urethra.
  • Additionally, it is contemplated that all components of the anchor assembly or selected portions thereof (of any of the anchor assemblies described or contemplated), may be coated or embedded with therapeutic or diagnostic substances (e.g. drugs or therapeutic agents). Again, in the context of treating a prostate gland, the anchor assembly can be coated or imbedded with substances such as 5-alpha-reductase which cause the prostate to decrease in size. Other substances contemplated include but are not limited to phytochemicals generally, alpha-1a-adrenergic receptor blocking agents, smooth muscle relaxants, and agents that inhibit the conversion of testosterone to dihydrotestosterone. In one particular approach, the connector 95 can for example, be coated with a polymer matrix or gel coating which retains the therapeutic or diagnostic substance and facilitates accomplishing the timed release thereof. Additionally, it is contemplated that bacteriostatic coatings as well as analgesics and antibiotics for prostatitis and other chemical coatings for cancer treatment, can be applied to various portions of the anchor assemblies described herein. Such coatings can have various thicknesses or a specific thickness such that it along with the connector itself matches the profile of a cylindrical portion of an anchor member affixed to the connector. Moreover, the co-delivery of a therapeutic or diagnostic gel or other substances through the implant deployment device or another medical device (i.e. catheter), and moreover an anchor assembly including the same, is within the scope of the present invention as is radio-loading devices (such as a capsular or distal ends of implants for cancer or other treatment modalities). In one such approach, the deployment device includes a reservoir holding the gel substance and through which an anchor device can be advance to pick up a desired quantity of therapeutic or diagnostic gel substance.
  • It is to be recognized that the timing of the dual advancement of the needle and connector assemblies and subsequent relative motion between the assemblies is coordinated. That is, the needle assembly first provides access to an interventional site and then the connector assembly is left extending beyond a terminal end of the needle assembly through the relative motion of the needle and connector assemblies.
  • It is further contemplated that in certain embodiments, the anchor delivery device can include the ability to detect forces being applied thereby or other environmental conditions. Various sections of the device can include such devices and in one contemplated approach sensors can be placed along the needle assembly. In this way, an operator can detect for example, whether the needle has breached the target anatomical structure at the interventional site and the extent to which such breaching has occurred. Other sensors which can detect particular environmental features can also be employed such as blood or other chemical or constituent sensors. Moreover, one or more pressure sensors or sensors providing feedback on the state of deployment of the anchor assembly during delivery or after implantation are contemplated. For example, tension or depth feedback can be monitored by these sensors. Further, such sensors can be incorporated into the anchor assembly itself, other structure of the deployment device or in the anatomy.
  • Moreover, it is to be recognized that the foregoing procedure is reversible. In one approach, the connection of an anchor assembly can be severed and a proximal (or second) anchor component removed from the patient's body. For example, the physician can simply cut the connector and simultaneously remove the second anchor previously implanted for example, in the patient's urethra using electrosurgical, surgical or laser surgical devices used in performing transurethral prostate resection.
  • An aspect that the various embodiments of the present invention provide is the ability to deliver multiple, anchor assemblies having a customizable length and distal anchor components, each anchor assembly being implanted at a different location without having to remove the device from the patient. The various embodiments provide for variable needle depth and variable connector length for each of the multiple anchor assemblies delivered. Other aspects of the various embodiments of the present invention are load-based delivery, preferably 1 pound, of an anchor assembly, anchor assembly delivery with a device having integrated connector, (e.g. suture), cutting, and anchor assembly delivery with an endoscope in the device. The delivery device is uniquely configured to place such a load (half pound to five pounds) between spaced first anchor members as well as between or on an implanted first anchor to help ensure that the first anchor component sits firmly against a tissue plane (e.g., the outer capsule of the prostate) and is held relatively firm as the second anchor component is attached to the connector and the delivery device. In this aspect, the needle assembly acting as a penetrating member can be cooperatively connected to a mechanism which produces a desired tension between the various anchor members while the needle assembly is retracted. Moreover, this load can be accomplished between first and second implanted anchor members.
  • It is to be recognized that various materials are within the scope of the present invention for manufacturing the disclosed devices. Moreover, one or more components such as distal anchor, proximal anchor, connector, of the one or more anchor devices disclosed herein may be designed to be completely or partially biodegradable or biofragmentable.
  • Further, as stated, the devices and methods disclosed herein may be used to treat a variety of pathologies in a variety of lumens or organs comprising a cavity or a wall. Examples of such lumens or organs include, but are not limited to urethra, bowel, stomach, esophagus, trachea, bronchii, bronchial passageways, veins (e.g. for treating varicose veins or valvular insufficiency), arteries, lymphatic vessels, ureters, bladder, cardiac atria or ventricles, uterus, fallopian tubes, etc.
  • Finally, it is to be appreciated that the invention has been described hereabove with reference to certain examples or embodiments of the invention but that various additions, deletions, alterations and modifications may be made to those examples and embodiments without departing from the intended spirit and scope of the invention. For example, any element or attribute of one embodiment or example may be incorporated into or used with another embodiment or example, unless to do so would render the embodiment or example unpatentable or unsuitable for its intended use. Also, for example, where the steps of a method are described or listed in a particular order, the order of such steps may be changed unless to do so would render the method unpatentable or unsuitable for its intended use. All reasonable additions, deletions, modifications and alterations are to be considered equivalents of the described examples and embodiments and are to be included within the scope of the following claims.
  • Thus, it will be apparent from the foregoing that, while particular forms of the invention have been illustrated and described, various modifications can be made without parting from the spirit and scope of the invention.

Claims (22)

1. A system for treatment of body tissue, comprising:
an anchor assembly, the anchor assembly including a first component and a second component; and
a delivery device, the delivery device including a needle assembly, a needle deploy actuator and a retract lever;
wherein the actuator accomplishes automated deployment of the needle assembly along a curved trajectory and the lever accomplishes manual withdrawal of the needle assembly.
2. The system of claim 1, wherein the delivery device includes a needle deployment spring and actuation of the actuator results in the needle deployment spring automatically advancing the needle assembly with a force sufficient to penetrate through and beyond a prostate and outer capsule of the prostate.
3. The system of claim 2, wherein the delivery device includes a spool assembly controlling the position of the needle assembly.
4. The system of claim 3, wherein the spool assembly includes the needle deployment spring.
5. The system of claim 4, wherein the delivery device includes a cartridge assembly, the cartridge assembly housing one anchor component.
6. The system of claim 5, wherein the cartridge assembly is configured to releasably engage the spool assembly.
7. The system of claim 6, wherein the cartridge assembly is configured to feed the one anchor component within the needle assembly.
8. The system of claim 7, wherein the cartridge assembly includes a spring.
9. The system of claim 8, wherein a clutch is provided to disassociate the cartridge assembly from at least a portion of the spool assembly.
10. The system of claim 9, wherein the spring is configured to apply a tension on the one anchor component.
11. The system of claim 10, wherein the delivery device includes a trigger assembly.
12. The system of claim 11, wherein the trigger assembly is configured to effect assembly of the anchor assembly.
13. The system of claim 12, wherein the trigger assembly controls severing of a third component of the anchor assembly.
14. The system of claim 13, wherein the delivery device includes a bail-out assembly configured to sever the third component of the anchor assembly.
15. The system of claim 14, wherein the delivery device includes a first reset lever configured to reset the needle spool assembly.
16. The system of claim 15, wherein the delivery device includes a second reset lever configured to reset the trigger assembly.
17. A system for treatment of body tissue, comprising:
an anchor assembly; and
a delivery device including a needle assembly, a spool assembly, a trigger assembly, a first actuator, a second actuator and a third actuator;
wherein actuation of the first actuator advances the needle assembly and a portion of the anchor assembly along a curved trajectory, actuation of the second actuator withdraws the needle assembly and actuation of the third actuator accomplishes assembly of the anchor assembly.
18. The system of claim 17, wherein the delivery device includes a first reset lever and a second reset lever, wherein the first reset lever resets the spool assembly and the second reset lever resets the trigger assembly.
19. The system of claim 18, wherein the delivery device includes a bail-out assembly and actuation of the bail-out assembly accomplishes severing a component of the anchor assembly.
20. The system of claim 17, wherein the delivery device includes a lock-out assembly which locks the lever until after depression of the first actuator.
21. The system of claim 17, wherein the delivery device includes a locking mechanism which locks the lever in a depressed condition.
22. The system of claim 17, wherein the delivery device includes structure to avoid premature deployment of the third actuator until the second actuator is fully depressed.
US13/489,793 2005-05-20 2012-06-06 Anchor delivery system with replaceable cartridge Abandoned US20120245600A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/489,793 US20120245600A1 (en) 2005-05-20 2012-06-06 Anchor delivery system with replaceable cartridge

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11/134,870 US7758594B2 (en) 2005-05-20 2005-05-20 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/318,246 US7645286B2 (en) 2005-05-20 2005-12-22 Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US11/492,690 US7896891B2 (en) 2005-05-20 2006-07-24 Apparatus and method for manipulating or retracting tissue and anatomical structure
US11/671,914 US8157815B2 (en) 2005-05-20 2007-02-06 Integrated handle assembly for anchor delivery system
US11/775,162 US8945152B2 (en) 2005-05-20 2007-07-09 Multi-actuating trigger anchor delivery system
US8493708P 2008-07-30 2008-07-30
US12/512,674 US8216254B2 (en) 2005-05-20 2009-07-30 Anchor delivery system with replaceable cartridge
US13/489,793 US20120245600A1 (en) 2005-05-20 2012-06-06 Anchor delivery system with replaceable cartridge

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/512,674 Continuation US8216254B2 (en) 2005-05-20 2009-07-30 Anchor delivery system with replaceable cartridge

Publications (1)

Publication Number Publication Date
US20120245600A1 true US20120245600A1 (en) 2012-09-27

Family

ID=41137066

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/512,674 Active 2026-01-12 US8216254B2 (en) 2005-05-20 2009-07-30 Anchor delivery system with replaceable cartridge
US13/489,793 Abandoned US20120245600A1 (en) 2005-05-20 2012-06-06 Anchor delivery system with replaceable cartridge

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/512,674 Active 2026-01-12 US8216254B2 (en) 2005-05-20 2009-07-30 Anchor delivery system with replaceable cartridge

Country Status (5)

Country Link
US (2) US8216254B2 (en)
EP (3) EP2345374B1 (en)
JP (2) JP5571079B2 (en)
CN (1) CN102112064B (en)
WO (1) WO2010014821A2 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10105132B2 (en) 2005-05-20 2018-10-23 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10143461B2 (en) 2005-05-20 2018-12-04 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10265061B2 (en) 2005-05-20 2019-04-23 Neotract, Inc. Latching anchor device
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10299780B2 (en) 2005-05-20 2019-05-28 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
US10426509B2 (en) 2005-05-20 2019-10-01 Neotract, Inc. Median lobe destruction apparatus and method
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US10492792B2 (en) 2005-05-20 2019-12-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US11298115B2 (en) 2020-08-03 2022-04-12 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions
US11672520B2 (en) 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1932484B1 (en) 2002-06-11 2011-04-27 Tyco Healthcare Group LP Hernia mesh tacks
US7670362B2 (en) 2003-06-13 2010-03-02 Tyco Healthcare Group Lp Multiple member interconnect for surgical instrument and absorbable screw fastener
US8926637B2 (en) 2003-06-13 2015-01-06 Covidien Lp Multiple member interconnect for surgical instrument and absorbable screw fastener
US10478179B2 (en) 2004-04-27 2019-11-19 Covidien Lp Absorbable fastener for hernia mesh fixation
US8333776B2 (en) * 2005-05-20 2012-12-18 Neotract, Inc. Anchor delivery system
US8425535B2 (en) 2005-05-20 2013-04-23 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8491606B2 (en) 2005-05-20 2013-07-23 Neotract, Inc. Median lobe retraction apparatus and method
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
US8944990B2 (en) * 2008-10-27 2015-02-03 Ams Research Corporation Surgical needle and anchor system with retractable features
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
GB2486497B (en) 2010-12-17 2013-06-19 Neosurgical Ltd Laparoscopic trocar system
US9855031B2 (en) 2010-04-13 2018-01-02 Neosurgical Limited Suture delivery system
US9161749B2 (en) 2011-04-14 2015-10-20 Neotract, Inc. Method and apparatus for treating sexual dysfunction
US9461793B2 (en) 2011-11-01 2016-10-04 Lg Electronics Inc. Method for determining the transmission of a sounding reference signal in a wireless communication system, and terminal therefor
US9445899B2 (en) 2012-08-22 2016-09-20 Joseph M. Arcidi Method and apparatus for mitral valve annuloplasty
US9358010B2 (en) 2013-03-12 2016-06-07 Covidien Lp Flex cable and spring-loaded tube for tacking device
US9867620B2 (en) 2013-03-14 2018-01-16 Covidien Lp Articulation joint for apparatus for endoscopic procedures
US9655621B2 (en) 2013-03-15 2017-05-23 Covidien Lp Surgical instrument for dispensing tacks and solution
US9668730B2 (en) * 2013-06-28 2017-06-06 Covidien Lp Articulating apparatus for endoscopic procedures with timing system
US9351728B2 (en) 2013-06-28 2016-05-31 Covidien Lp Articulating apparatus for endoscopic procedures
US9358004B2 (en) 2013-06-28 2016-06-07 Covidien Lp Articulating apparatus for endoscopic procedures
US10085746B2 (en) 2013-06-28 2018-10-02 Covidien Lp Surgical instrument including rotating end effector and rotation-limiting structure
US20150032130A1 (en) 2013-07-24 2015-01-29 Covidien Lp Expanding absorbable tack
US9526498B2 (en) 2013-09-17 2016-12-27 Covidien Lp Surgical device with a trigger lockout mechanism device
WO2015149292A1 (en) * 2014-04-02 2015-10-08 Covidien Lp Surgical fastener applying apparatus, kits and methods for endoscopic procedures
US9877714B2 (en) 2014-06-04 2018-01-30 Neotract, Inc. System with reloadable handle for delivering an anchor
US9480565B2 (en) 2015-02-02 2016-11-01 On-X Life Technologies, Inc. Rapid deployment artificial chordae tendinae system
US11090097B2 (en) 2015-03-17 2021-08-17 Covidien Lp Connecting end effectors to surgical devices
CN104964143B (en) * 2015-07-01 2018-02-13 孙习习 A kind of acupuncture needle rod display unit
US11045191B2 (en) * 2016-04-01 2021-06-29 Cilag Gmbh International Method for operating a surgical stapling system
WO2017210434A1 (en) 2016-06-01 2017-12-07 On-X Life Technologies, Inc. Pull-through chordae tendineae system
CN107233142B (en) * 2016-10-08 2024-02-13 优诺维(武汉)医疗科技有限公司 Proliferation tissue interventional therapy apparatus
US10743859B2 (en) 2016-10-21 2020-08-18 Covidien Lp Surgical end effectors
US11298123B2 (en) 2016-10-21 2022-04-12 Covidien Lp Surgical end effectors
US10617409B2 (en) 2016-10-21 2020-04-14 Covidien Lp Surgical end effectors
US10888309B2 (en) 2017-01-31 2021-01-12 Covidien Lp Surgical fastener devices with geometric tubes
WO2018223324A1 (en) * 2017-06-08 2018-12-13 Covidien Lp Adjustable rotation assembly for surgical instruments
CA3092566C (en) * 2018-03-23 2023-09-19 Conmed Corporation Suture anchor driver
US11298126B2 (en) 2018-05-02 2022-04-12 Covidien Lp Shipping wedge for end effector installation onto surgical devices
US11116500B2 (en) 2018-06-28 2021-09-14 Covidien Lp Surgical fastener applying device, kits and methods for endoscopic procedures
SI3823542T1 (en) * 2018-07-16 2022-05-31 OCAK, Ubbat A suture member, suturing needle and suturing device
CN110327129A (en) * 2019-04-25 2019-10-15 卢乐 Restorer for the operation of ox abomasal displacement
JP7299337B2 (en) * 2019-06-11 2023-06-27 ボストン サイエンティフィック サイムド,インコーポレイテッド Devices, devices and methods for increasing force distribution at the suture-tissue interface
US11523817B2 (en) 2019-06-27 2022-12-13 Covidien Lp Endoluminal pursestring device
CN110584853B (en) * 2019-11-13 2020-02-07 微创优通医疗科技(上海)有限公司 Operating system, implant delivery system and delivery method
US11197675B2 (en) 2019-12-19 2021-12-14 Covidien Lp Positioning guide for surgical instruments and surgical instrument systems
USD944985S1 (en) 2019-12-19 2022-03-01 Covidien Lp Positioning guide cuff
USD944984S1 (en) 2019-12-19 2022-03-01 Covidien Lp Tubular positioning guide
WO2021168057A1 (en) 2020-02-21 2021-08-26 Neotract, Inc. Apparatus for preventing device deployment failure
KR102170400B1 (en) * 2020-08-31 2020-10-27 정윤호 Prostate enlargement treatment device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5921982A (en) * 1993-07-30 1999-07-13 Lesh; Michael D. Systems and methods for ablating body tissue
US20050251177A1 (en) * 2004-05-07 2005-11-10 Usgi Medical Inc. Apparatus and methods for rapid deployment of tissue anchors

Family Cites Families (332)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734299A (en) * 1956-02-14 Igudolph
US659422A (en) * 1900-06-12 1900-10-09 George W Shidler Surgical instrument.
US789467A (en) * 1903-06-12 1905-05-09 Stillman A West Method of tying knots.
US780392A (en) * 1903-09-14 1905-01-17 Brown Straw Binder Company Straw-bundle tie.
US2579192A (en) * 1950-08-15 1951-12-18 George H Sciaroni Suturing instrument
US2697624A (en) * 1951-11-03 1954-12-21 John A Thomas Portable knot tying device
US2646298A (en) * 1952-07-15 1953-07-21 Joseph C Leary Method of knot tying
US2825592A (en) * 1954-01-06 1958-03-04 Semple James Mckenzie Portable knot tying device for smooth filaments
US3326586A (en) * 1965-07-09 1967-06-20 Robert M Frost Snell knot tying tool
US3470834A (en) * 1968-03-08 1969-10-07 Dennison Mfg Co Fastener attaching device
US3521918A (en) * 1968-08-14 1970-07-28 Richard L Hammond Fishline knotting fixture and cutter
US3664345A (en) * 1970-07-06 1972-05-23 Clyde Harwell Dabbs Surgical buttons
US3716058A (en) * 1970-07-17 1973-02-13 Atlanta Res Inst Barbed suture
US3713680A (en) * 1971-02-09 1973-01-30 S Pagano Knot typing device for barrel knots
US3756638A (en) * 1972-02-22 1973-09-04 L Stockberger Knot tyer
US3875648A (en) * 1973-04-04 1975-04-08 Dennison Mfg Co Fastener attachment apparatus and method
US3873140A (en) * 1973-10-15 1975-03-25 Moodus Sports Products Fish hook holder and knot tying device
US3931667A (en) * 1974-05-08 1976-01-13 Dennison Manufacturing Company Interlocking attachment device
US3976079A (en) * 1974-08-01 1976-08-24 Samuels Peter B Securing devices for sutures
US4006747A (en) * 1975-04-23 1977-02-08 Ethicon, Inc. Surgical method
US4235238A (en) * 1978-05-11 1980-11-25 Olympus Optical Co., Ltd. Apparatus for suturing coeliac tissues
US4210148A (en) * 1978-11-03 1980-07-01 Stivala Oscar G Retention suture system
DE2853289C2 (en) * 1978-12-09 1980-12-18 B. Braun Melsungen Ag, 3508 Melsungen Button for surgical use
US4409974A (en) * 1981-06-29 1983-10-18 Freedland Jeffrey A Bone-fixating surgical implant device
US4513746A (en) * 1981-10-09 1985-04-30 United States Surgical Corp. Instrument for applying plastic-like surgical fastening devices
US6656182B1 (en) 1982-05-20 2003-12-02 John O. Hayhurst Tissue manipulation
US5417691A (en) 1982-05-20 1995-05-23 Hayhurst; John O. Apparatus and method for manipulating and anchoring tissue
US4741330A (en) * 1983-05-19 1988-05-03 Hayhurst John O Method and apparatus for anchoring and manipulating cartilage
US4823794A (en) * 1982-07-12 1989-04-25 Pierce William S Surgical pledget
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5370675A (en) * 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US4493323A (en) * 1982-12-13 1985-01-15 University Of Iowa Research Foundation Suturing device and method for using same
US4621640A (en) * 1984-01-09 1986-11-11 Mulhollan James S Mechanical needle carrier and method for its use
US4657461A (en) * 1984-10-26 1987-04-14 Smith Gareth J Anchoring bolt
US4750492A (en) * 1985-02-27 1988-06-14 Richards Medical Company Absorbable suture apparatus, method and installer
US4955913A (en) * 1985-03-28 1990-09-11 Robinson Walter C Surgical tie
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US4705040A (en) * 1985-11-18 1987-11-10 Medi-Tech, Incorporated Percutaneous fixation of hollow organs
US4738255A (en) * 1986-04-07 1988-04-19 Biotron Labs, Inc. Suture anchor system
US5123914A (en) 1986-05-19 1992-06-23 Cook Incorporated Visceral anchor for visceral wall mobilization
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4714281A (en) * 1987-01-02 1987-12-22 Peck Richard M Device and method for tying a twisted clinch knot
US4744364A (en) * 1987-02-17 1988-05-17 Intravascular Surgical Instruments, Inc. Device for sealing percutaneous puncture in a vessel
US4898156A (en) * 1987-05-18 1990-02-06 Mitek Surgical Products, Inc. Suture anchor
US4899743A (en) * 1987-12-15 1990-02-13 Mitek Surgical Products, Inc. Suture anchor installation tool
US4968315A (en) * 1987-12-15 1990-11-06 Mitek Surgical Products, Inc. Suture anchor and suture anchor installation tool
US4926860A (en) * 1988-02-05 1990-05-22 Flexmedics Corporation ARthroscopic instrumentation and method
US5053046A (en) * 1988-08-22 1991-10-01 Woodrow W. Janese Dural sealing needle and method of use
US5904679A (en) 1989-01-18 1999-05-18 Applied Medical Resources Corporation Catheter with electrosurgical cutter
CA2053909A1 (en) * 1989-05-03 1990-11-04 Robert A. Roth Instrument and method for intraluminally relieving stenosis
US5002550A (en) * 1989-06-06 1991-03-26 Mitek Surgical Products, Inc. Suture anchor installation tool
US4946468A (en) * 1989-06-06 1990-08-07 Mitek Surgical Products, Inc. Suture anchor and suture anchor installation tool
RU2062121C1 (en) 1989-10-13 1996-06-20 Давыдов Владимир Александрович Dilating device
US5919202A (en) 1989-12-05 1999-07-06 Yoon; Inbae Surgical instrument with jaws and movable internal needle and method for use thereof
US5267960A (en) 1990-03-19 1993-12-07 Omnitron International Inc. Tissue engaging catheter for a radioactive source wire
US5080660A (en) * 1990-05-11 1992-01-14 Applied Urology, Inc. Electrosurgical electrode
US5269809A (en) 1990-07-02 1993-12-14 American Cyanamid Company Locking mechanism for use with a slotted suture anchor
US5041129A (en) * 1990-07-02 1991-08-20 Acufex Microsurgical, Inc. Slotted suture anchor and method of anchoring a suture
US5236445A (en) * 1990-07-02 1993-08-17 American Cyanamid Company Expandable bone anchor and method of anchoring a suture to a bone
US5203787A (en) * 1990-11-19 1993-04-20 Biomet, Inc. Suture retaining arrangement
US5129912B2 (en) * 1991-01-07 2000-01-11 Urohealth Systems Inc Device and method for applying suture
US5100421A (en) * 1991-02-05 1992-03-31 Cyprus Endosurgical Tools, Inc. Christoudias curved needle suture assembly
DE4106823C1 (en) * 1991-03-04 1992-06-25 Liebscher Kunststofftechnik, 8032 Graefelfing, De
US5405352A (en) * 1991-04-09 1995-04-11 Weston; Peter V. Suture knot, method for its formation and use, and knot forming apparatus
US5217470A (en) * 1991-04-29 1993-06-08 Weston Peter V Apparatuses and methods for formation and use of a slipknot as a surgical suture knot
US5258015A (en) * 1991-05-03 1993-11-02 American Cyanamid Company Locking filament caps
US5234454A (en) * 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US5861002A (en) 1991-10-18 1999-01-19 Desai; Ashvin H. Endoscopic surgical instrument
US5411520A (en) * 1991-11-08 1995-05-02 Kensey Nash Corporation Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and method of use
ATE176998T1 (en) 1991-12-03 1999-03-15 Boston Scient Ireland Ltd INSTRUMENT FOR PASSING A SEWING THREAD
US5217486A (en) * 1992-02-18 1993-06-08 Mitek Surgical Products, Inc. Suture anchor and installation tool
US5540704A (en) * 1992-09-04 1996-07-30 Laurus Medical Corporation Endoscopic suture system
US5578044A (en) * 1992-09-04 1996-11-26 Laurus Medical Corporation Endoscopic suture system
US6048351A (en) 1992-09-04 2000-04-11 Scimed Life Systems, Inc. Transvaginal suturing system
US5364408A (en) * 1992-09-04 1994-11-15 Laurus Medical Corporation Endoscopic suture system
US7060077B2 (en) 1992-09-04 2006-06-13 Boston Scientific Scimed, Inc. Suturing instruments and methods of use
US5322501A (en) * 1992-10-02 1994-06-21 Mahmud Durrani Ayaz Continent urethral stent for treating and preventing urethral stricture after surgery
US5368599A (en) * 1992-10-08 1994-11-29 United States Surgical Corporation Surgical fastening apparatus with suture array
IL103737A (en) 1992-11-13 1997-02-18 Technion Res & Dev Foundation Stapler device particularly useful in medical suturing
US5370646A (en) * 1992-11-16 1994-12-06 Reese; H. William Bone clamp and installation tool
US5814073A (en) 1996-12-13 1998-09-29 Bonutti; Peter M. Method and apparatus for positioning a suture anchor
US5380334A (en) * 1993-02-17 1995-01-10 Smith & Nephew Dyonics, Inc. Soft tissue anchors and systems for implantation
US5735861A (en) 1995-09-06 1998-04-07 Wilson-Cook Medical, Inc. Channel mounted activating mechanism for an endoscopic ligator
US5334200A (en) * 1993-03-02 1994-08-02 Lanny L. Johnson Suture knot making device and method for use
US5330488A (en) * 1993-03-23 1994-07-19 Goldrath Milton H Verres needle suturing kit
SE505436C2 (en) 1993-04-27 1997-08-25 Ams Medinvent Sa prostatic stent
US5549630A (en) * 1993-05-14 1996-08-27 Bonutti; Peter M. Method and apparatus for anchoring a suture
US5403348A (en) 1993-05-14 1995-04-04 Bonutti; Peter M. Suture anchor
US5845645A (en) 1993-05-14 1998-12-08 Bonutti; Peter M. Method of anchoring a suture
US5716368A (en) 1993-06-02 1998-02-10 General Surgical Innovations, Inc. Knotmaker with curved elongate member used in tying a ligature
US5472446A (en) * 1993-06-02 1995-12-05 De La Torre; Roger A. Surgical instrument for tying a knot in a length of suture at a remote location
US5505735A (en) * 1993-06-10 1996-04-09 Mitek Surgical Products, Inc. Surgical anchor and method for using the same
US5500000A (en) 1993-07-01 1996-03-19 United States Surgical Corporation Soft tissue repair system and method
US5499994A (en) * 1993-07-30 1996-03-19 American Medical Systems, Inc. Dilation device for the urethra
US5391182A (en) * 1993-08-03 1995-02-21 Origin Medsystems, Inc. Apparatus and method for closing puncture wounds
US5354271A (en) * 1993-08-05 1994-10-11 Voda Jan K Vascular sheath
US5507754A (en) * 1993-08-20 1996-04-16 United States Surgical Corporation Apparatus and method for applying and adjusting an anchoring device
CA2124651C (en) * 1993-08-20 2004-09-28 David T. Green Apparatus and method for applying and adjusting an anchoring device
US5899911A (en) 1993-08-25 1999-05-04 Inlet Medical, Inc. Method of using needle-point suture passer to retract and reinforce ligaments
US5417690A (en) * 1993-09-20 1995-05-23 Codman & Shurtleff, Inc. Surgical cable
US5536273A (en) 1993-12-09 1996-07-16 Lehrer; Theodor Apparatus and method of extracorporeally applying and locking laparoscopic suture and loop ligatures
AU1011595A (en) 1994-01-13 1995-07-20 Ethicon Inc. Spiral surgical tack
US5690677A (en) 1994-02-17 1997-11-25 Arthrex, Inc. Method for installing a suture anchor through a cannulated tissue-shifting guide
CA2141911C (en) 1994-02-24 2002-04-23 Jude S. Sauer Surgical crimping device and method of use
US5545178A (en) * 1994-04-29 1996-08-13 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5470337A (en) * 1994-05-17 1995-11-28 Moss; Gerald Surgical fastener
US5630824A (en) 1994-06-01 1997-05-20 Innovasive Devices, Inc. Suture attachment device
US5573540A (en) * 1994-07-18 1996-11-12 Yoon; Inbae Apparatus and method for suturing an opening in anatomical tissue
US5501690A (en) * 1994-09-02 1996-03-26 Ethicon Endo-Surgery Suturing device
US5545171A (en) * 1994-09-22 1996-08-13 Vidamed, Inc. Anastomosis catheter
US5480406A (en) * 1994-10-07 1996-01-02 United States Surgical Corporation Method of employing surgical suturing apparatus to tie knots
US5531763A (en) * 1994-10-07 1996-07-02 United States Surgical Corporation Suture cinching apparatus
US5554162A (en) * 1994-12-02 1996-09-10 Delange; Gregory S. Method and device for surgically joining luminal structures
IL111985A (en) 1994-12-14 1999-04-11 Medical Influence Technologies Staple and thread assembly particularly for use in power-driven staplers for medical suturing
US5665109A (en) 1994-12-29 1997-09-09 Yoon; Inbae Methods and apparatus for suturing tissue
US5550172A (en) * 1995-02-07 1996-08-27 Ethicon, Inc. Utilization of biocompatible adhesive/sealant materials for securing surgical devices
RU2112571C1 (en) 1995-04-11 1998-06-10 Педдер Валерий Викторович Method for treatment of chronic prostatitis and device for its realization (variants)
US6117161A (en) 1995-06-06 2000-09-12 Li Medical Tecnologies, Inc. Fastener and fastening method, particularly for fastening sutures to bone
US5593421A (en) 1995-06-06 1997-01-14 Bauer; William Suture element delivery device and method
US6086608A (en) 1996-02-22 2000-07-11 Smith & Nephew, Inc. Suture collet
US5647836A (en) 1995-09-28 1997-07-15 Blake, Iii; Joseph W. Method and means for treating female urinary incontinence
US5800445A (en) 1995-10-20 1998-09-01 United States Surgical Corporation Tissue tagging device
CA2187975C (en) 1995-10-20 2001-05-01 Lisa W. Heaton Surgical apparatus and method for marking tissue location
US5690649A (en) 1995-12-05 1997-11-25 Li Medical Technologies, Inc. Anchor and anchor installation tool and method
US5725556A (en) 1995-12-15 1998-03-10 M & R Medical, Inc. Suture locking apparatus
US5626614A (en) 1995-12-22 1997-05-06 Applied Medical Resources Corporation T-anchor suturing device and method for using same
US5707394A (en) 1996-02-07 1998-01-13 Bristol-Myers Squibb Company Pre-loaded suture anchor with rigid extension
US5697950A (en) 1996-02-07 1997-12-16 Linvatec Corporation Pre-loaded suture anchor
US6436107B1 (en) 1996-02-20 2002-08-20 Computer Motion, Inc. Method and apparatus for performing minimally invasive surgical procedures
US5741276A (en) 1996-03-28 1998-04-21 Innovative Surgical Instruments Apparatus for facilitating the performance of surgical procedures such as the placement of sutures, ligatures and the like
US5830179A (en) 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
DE69736174T2 (en) 1996-04-19 2007-05-16 Applied Medical Resources Corp., Laguna Hills DEVICE FOR MOUNTING HOLDING CLIPS
US5746753A (en) 1996-05-13 1998-05-05 Boston Scientific Corporation Needle grasping apparatus
FR2750031B1 (en) 1996-06-19 1998-09-18 Martin Jean Jacques BONE ANCHORING DEVICE FOR SUTURE WIRE AND INSTRUMENT FOR THE IMPLEMENTATION OF THIS DEVICE
US5782862A (en) 1996-07-01 1998-07-21 Bonutti; Peter M. Suture anchor inserter assembly and method
US5718717A (en) 1996-08-19 1998-02-17 Bonutti; Peter M. Suture anchor
US5752963A (en) 1996-08-19 1998-05-19 Bristol-Myers Squibb Company Suture anchor driver
US5810848A (en) 1996-08-21 1998-09-22 Hayhurst; John O. Suturing system
US5830221A (en) 1996-09-20 1998-11-03 United States Surgical Corporation Coil fastener applier
US5948001A (en) 1996-10-03 1999-09-07 United States Surgical Corporation System for suture anchor placement
US5948002A (en) 1996-11-15 1999-09-07 Bonutti; Peter M. Apparatus and method for use in positioning a suture anchor
US5814072A (en) 1996-11-15 1998-09-29 Bonutti; Peter M. Method and apparatus for use in anchoring a suture
CA2224366C (en) 1996-12-11 2006-10-31 Ethicon, Inc. Meniscal repair device
US5928252A (en) 1997-01-21 1999-07-27 Regen Biologics, Inc. Device and method for driving a needle and meniscal repair
US5964732A (en) 1997-02-07 1999-10-12 Abbeymoor Medical, Inc. Urethral apparatus with position indicator and methods of use thereof
US5954057A (en) 1997-02-12 1999-09-21 Li Medical Technologies, Inc. Soft tissue suspension clip, clip assembly, emplacement tool and method
US5782864A (en) 1997-04-03 1998-07-21 Mitek Surgical Products, Inc. Knotless suture system and method
US5846254A (en) 1997-04-08 1998-12-08 Ethicon Endo-Surgery, Inc. Surgical instrument for forming a knot
US5964756A (en) 1997-04-11 1999-10-12 Vidamed, Inc. Transurethral needle ablation device with replaceable stylet cartridge
US5919198A (en) 1997-04-17 1999-07-06 Ethicon Endo-Surgery, Inc. Disposable cartridge with drivers
US6120539A (en) 1997-05-01 2000-09-19 C. R. Bard Inc. Prosthetic repair fabric
US5908428A (en) 1997-05-27 1999-06-01 United States Surgical Corporation Stitching devices for heart valve replacement surgery
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
FR2765732B1 (en) 1997-07-04 1999-08-27 France Telecom VARIABLE PROPELLER ANTENNA
US5899921A (en) 1997-07-25 1999-05-04 Innovasive Devices, Inc. Connector device and method for surgically joining and securing flexible tissue repair members
US6159234A (en) 1997-08-01 2000-12-12 Peter M. Bonutti Method and apparatus for securing a suture
US6056722A (en) 1997-09-18 2000-05-02 Iowa-India Investments Company Limited Of Douglas Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use
US5868762A (en) 1997-09-25 1999-02-09 Sub-Q, Inc. Percutaneous hemostatic suturing device and method
US6551328B2 (en) 1997-11-03 2003-04-22 Symbiosis Corporation Surgical instrument for invagination and fundoplication
US5954747A (en) 1997-11-20 1999-09-21 Clark; Ron Meniscus repair anchor system
US6626919B1 (en) 1997-12-29 2003-09-30 Lee L. Swanstrom Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall
US6068648A (en) 1998-01-26 2000-05-30 Orthodyne, Inc. Tissue anchoring system and method
US5921986A (en) 1998-02-06 1999-07-13 Bonutti; Peter M. Bone suture
US6045551A (en) 1998-02-06 2000-04-04 Bonutti; Peter M. Bone suture
US6280460B1 (en) 1998-02-13 2001-08-28 Heartport, Inc. Devices and methods for performing vascular anastomosis
RU2128012C1 (en) 1998-03-11 1999-03-27 Оспанов Орал Базарбаевич Compression anastomosis apparatus
US5944739A (en) 1998-03-12 1999-08-31 Surgical Dynamics, Inc. Suture anchor installation system
US6010514A (en) 1998-03-17 2000-01-04 Burney; Bryan T. Suturing assembly and method of use
US5931844A (en) 1998-03-31 1999-08-03 Smith & Nephew, Inc. Surgical drive tool
US5971447A (en) 1998-04-15 1999-10-26 Steck, Iii; William F Fisherman's knot tying device
US6143006A (en) 1998-04-18 2000-11-07 Chan; Kwan-Ho Apparatus and method for tying and tensioning knots
US6080167A (en) 1998-04-28 2000-06-27 Lyell; Mark S. Anastomotic instrument
US6216703B1 (en) 1998-05-08 2001-04-17 Thermatrx, Inc. Therapeutic prostatic thermotherapy
US6740098B2 (en) 1998-05-11 2004-05-25 Surgical Connections, Inc. Surgical stabilizer devices and methods
AU737877B2 (en) 1998-05-21 2001-09-06 Christopher J. Walshe A tissue anchor system
US6488691B1 (en) 1998-06-24 2002-12-03 Brendan J. Carroll Laparascopic incision closure device
US6261302B1 (en) 1998-06-26 2001-07-17 Ethicon Endo-Surgery, Inc. Applier for implantable surgical marker
ATE347312T1 (en) 1998-08-10 2006-12-15 Coroneo Inc SURGICAL SUTURE MATERIAL USABLE AS A RETRACTOR WITH FASTENING MEANS
US6332889B1 (en) 1998-08-27 2001-12-25 Onux Medical, Inc. Surgical suturing instrument and method of use
US6200329B1 (en) 1998-08-31 2001-03-13 Smith & Nephew, Inc. Suture collet
US6093194A (en) 1998-09-14 2000-07-25 Endocare, Inc. Insertion device for stents and methods for use
US6030393A (en) 1998-09-15 2000-02-29 Corlew; Earvin L. Needle and procedure for relieving urinary incontinence
US6110183A (en) 1998-12-22 2000-08-29 Cook Incorporated Suture anchor device
EP1016377B1 (en) 1998-12-30 2006-04-26 Ethicon Inc. Suture locking device
EP2055244B1 (en) 1998-12-31 2012-02-01 Kensey Nash Corporation Tissue fastening devices
US6053908A (en) 1999-01-07 2000-04-25 Design Standards Corporation Ratchet assembly for surgical instrument
CA2362792A1 (en) 1999-03-03 2000-09-08 Smith & Nephew, Inc. Methods, systems, and instruments for inserting prosthetic implants
US8137364B2 (en) 2003-09-11 2012-03-20 Abbott Laboratories Articulating suturing device and method
US6228096B1 (en) 1999-03-31 2001-05-08 Sam R. Marchand Instrument and method for manipulating an operating member coupled to suture material while maintaining tension on the suture material
AU770243B2 (en) 1999-04-09 2004-02-19 Evalve, Inc. Methods and apparatus for cardiac valve repair
US6258124B1 (en) 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US6461355B2 (en) 1999-05-27 2002-10-08 Ams Research Corporation Insulated electrode and method of assembly
US6368346B1 (en) 1999-06-03 2002-04-09 American Medical Systems, Inc. Bioresorbable stent
US6821285B2 (en) 1999-06-22 2004-11-23 Ndo Surgical, Inc. Tissue reconfiguration
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US6663639B1 (en) 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US6835200B2 (en) 1999-06-22 2004-12-28 Ndo Surgical. Inc. Method and devices for tissue reconfiguration
US6506196B1 (en) 1999-06-22 2003-01-14 Ndo Surgical, Inc. Device and method for correction of a painful body defect
US7416554B2 (en) 2002-12-11 2008-08-26 Usgi Medical Inc Apparatus and methods for forming and securing gastrointestinal tissue folds
US6206895B1 (en) 1999-07-13 2001-03-27 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6592609B1 (en) 1999-08-09 2003-07-15 Bonutti 2003 Trust-A Method and apparatus for securing tissue
US6527794B1 (en) 1999-08-10 2003-03-04 Ethicon, Inc. Self-locking suture anchor
US6290711B1 (en) 1999-08-13 2001-09-18 Innovasive Devices, Inc. Connector device and method for surgically joining and securing flexible tissue repair members
US6425919B1 (en) 1999-08-18 2002-07-30 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
DE69924373T2 (en) 1999-09-10 2005-09-15 Zimmer Technology, Inc., Chicago Binding element for wound healing
US6358258B1 (en) 1999-09-14 2002-03-19 Abbott Laboratories Device and method for performing end-to-side anastomosis
US6641592B1 (en) 1999-11-19 2003-11-04 Lsi Solutions, Inc. System for wound closure
US7887551B2 (en) 1999-12-02 2011-02-15 Smith & Nephew, Inc. Soft tissue attachment and repair
US6635073B2 (en) 2000-05-03 2003-10-21 Peter M. Bonutti Method of securing body tissue
US6527702B2 (en) 2000-02-01 2003-03-04 Abbeymoor Medical, Inc. Urinary flow control device and method
US6706047B2 (en) 2000-02-15 2004-03-16 Eva Corporation Suture support assembly
WO2001066018A1 (en) 2000-03-03 2001-09-13 C. R. Bard, Inc. Endoscopic tissue apposition device with multiple suction ports
US6402750B1 (en) 2000-04-04 2002-06-11 Spinlabs, Llc Devices and methods for the treatment of spinal disorders
US6908473B2 (en) 2000-04-14 2005-06-21 Jeffry B. Skiba Tissue anchoring devices, biological vessel suspending devices and systems and methods utilizing same
US6663589B1 (en) 2000-06-20 2003-12-16 Haim Halevy Catheter system
US7141038B2 (en) 2000-08-07 2006-11-28 Abbeymoor Medical, Inc. Endourethral device and method
US6530932B1 (en) 2000-08-30 2003-03-11 Ethicon Endo-Surgery, Inc. Anastomosis device having improved tissue presentation
AU2001288573A1 (en) 2000-08-31 2002-03-13 Abbeymoor Medical, Inc. Diagnostic urethral assembly and method
US6322112B1 (en) 2000-09-14 2001-11-27 Franklin R. Duncan Knot tying methods and apparatus
US6533796B1 (en) 2000-10-11 2003-03-18 Lsi Solutions, Inc. Loader for surgical suturing instrument
US7485124B2 (en) 2000-10-19 2009-02-03 Ethicon Endo-Surgery, Inc. Surgical instrument having a fastener delivery mechanism
US6572626B1 (en) 2000-10-19 2003-06-03 Ethicon Endo-Surgery, Inc. Surgical instrument having a fastener delivery mechanism
US6551333B2 (en) 2000-10-19 2003-04-22 Ethicon Endo-Surgery, Inc. Method for attaching hernia mesh
US6425900B1 (en) 2000-10-19 2002-07-30 Ethicon Endo-Surgery Method for attaching hernia mesh
US6773438B1 (en) 2000-10-19 2004-08-10 Ethicon Endo-Surgery Surgical instrument having a rotary lockout mechanism
US6949064B2 (en) 2000-10-20 2005-09-27 Bard Brachytherapy, Inc. Brachytherapy seed deployment system
ATE417550T1 (en) 2000-11-02 2009-01-15 Smith & Nephew Inc CLOSURE DEVICE FOR RECOVERING TISSUE
EP1341483B1 (en) 2000-11-22 2008-08-27 Bard Peripheral Vascular, Inc. Method for the production of a high density microwall expanded polytetrafluoroethylene tubular structure
US6821282B2 (en) 2000-11-27 2004-11-23 Scimed Life Systems, Inc. Full thickness resection device control handle
US6398795B1 (en) 2000-11-30 2002-06-04 Scimed Life Systems, Inc. Stapling and cutting in resectioning for full thickness resection devices
US20020161382A1 (en) 2001-03-29 2002-10-31 Neisz Johann J. Implant inserted without bone anchors
DE60237884D1 (en) 2001-01-23 2010-11-18 Abbeymoor Medical Inc END EUROPEAN DEVICE
US20040030217A1 (en) 2001-02-02 2004-02-12 Yeung Jeffrey E Urethral muscle controlled micro-invasive sphincteric closure device
US6802846B2 (en) 2001-02-12 2004-10-12 Ams Research Corporation Foreign body retrieval device and method
US6770076B2 (en) 2001-02-12 2004-08-03 Opus Medical, Inc. Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
US7083638B2 (en) 2001-02-12 2006-08-01 Arthrocare Corporation Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
US6709493B2 (en) 2001-03-26 2004-03-23 Gore Enterprise Holdings, Inc. Device for reducing the presence of moisture within an enclosure containing a heat source
WO2002089566A1 (en) 2001-05-09 2002-11-14 Taiho Pharmaceutical Co., Ltd. Interstitial prostatism model animal
US6821291B2 (en) 2001-06-01 2004-11-23 Ams Research Corporation Retrievable stent and method of use thereof
US6926732B2 (en) 2001-06-01 2005-08-09 Ams Research Corporation Stent delivery device and method
CA2450662C (en) 2001-06-14 2010-06-15 Suturtek Incorporated Apparatus and method for surgical suturing with thread management
CA2451150C (en) 2001-06-22 2011-10-25 Abbeymoor Medical, Inc. Urethral profiling device & methodology
US7727248B2 (en) 2001-06-25 2010-06-01 Ethicon Endo-Surgery, Inc. Surgical clip
AU2002322493A1 (en) 2001-07-10 2003-01-29 Ams Research Corporation Surgical kit for treating prostate tissue
US6596013B2 (en) 2001-09-20 2003-07-22 Scimed Life Systems, Inc. Method and apparatus for treating septal defects
US6767037B2 (en) 2001-09-27 2004-07-27 Depuy Mitek, Inc. Sliding and locking surgical knot
US6773436B2 (en) 2001-09-28 2004-08-10 Depuy Mitek, Inc. Absorbable bone anchor
EP1434530A2 (en) 2001-10-12 2004-07-07 AMS Research Corporation Surgical instrument and method
ATE536198T1 (en) 2001-10-18 2011-12-15 Abbeymoor Medical Inc ENDOURETHRAL DEVICE
US20060167477A1 (en) 2001-11-20 2006-07-27 Arcia Rovil P Device and method for performing end-to-side anastomosis
DE10159470B4 (en) 2001-12-04 2012-12-13 Ovesco Endoscopy Gmbh Surgical instrument with anchor device at the head end
US6572653B1 (en) 2001-12-07 2003-06-03 Rush E. Simonson Vertebral implant adapted for posterior insertion
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
US6855115B2 (en) 2002-01-22 2005-02-15 Cardiomems, Inc. Implantable wireless sensor for pressure measurement within the heart
US7402166B2 (en) 2002-02-15 2008-07-22 A&P Feigl Family Limited Partnership Devices and methods for positioning sutures
RU2221501C2 (en) 2002-02-28 2004-01-20 Оспанов Орал Базарбаевич Method for laparoscopic performance of compression anastomosis
EP1482841B1 (en) 2002-03-14 2005-12-07 Yeung, Jeffery E. Suture anchor and approximating device
US6699263B2 (en) 2002-04-05 2004-03-02 Cook Incorporated Sliding suture anchor
US6951565B2 (en) * 2002-04-24 2005-10-04 Linvatec Biomaterials Ltd. Device for inserting surgical implants
US8105342B2 (en) 2002-05-08 2012-01-31 Apollo Endosurgery, Inc. Apparatus for ligating/suturing living tissues and system for resecting/suturing living tissues
US7011688B2 (en) 2002-05-10 2006-03-14 C.R. Bard, Inc. Prosthetic repair fabric
US6736823B2 (en) 2002-05-10 2004-05-18 C.R. Bard, Inc. Prosthetic repair fabric
US6736854B2 (en) 2002-05-10 2004-05-18 C. R. Bard, Inc. Prosthetic repair fabric with erosion resistant edge
JP4473115B2 (en) 2002-05-17 2010-06-02 タイコ ヘルスケア グループ エルピー Endoscopic organ traction system and method of use thereof
EP1509256B1 (en) 2002-05-24 2009-07-22 Angiotech International Ag Compositions and methods for coating medical implants
US7758637B2 (en) 2003-02-06 2010-07-20 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US8287555B2 (en) 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
AU2003245507A1 (en) 2002-06-13 2003-12-31 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US7753922B2 (en) 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US7753858B2 (en) 2002-06-13 2010-07-13 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20050216078A1 (en) 2002-06-13 2005-09-29 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7666193B2 (en) 2002-06-13 2010-02-23 Guided Delivery Sytems, Inc. Delivery devices and methods for heart valve repair
US7753924B2 (en) 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US6715804B2 (en) 2002-07-05 2004-04-06 Daniel James Beers Fisherman's knot tier
US7094199B2 (en) 2002-07-23 2006-08-22 Sherwood Services Ag Ivs obturator instrument and procedure
EA007116B1 (en) 2002-08-23 2006-06-30 Квинно Сентр Пти Лтд. Anchoring device and its implementation
US7329264B2 (en) 2002-10-07 2008-02-12 Arthrex, Inc. Instrument handle for storing suture and needles
US6821283B2 (en) 2002-10-16 2004-11-23 Civco Medical Instruments, Inc. Suturing system and method
US7105004B2 (en) 2002-10-21 2006-09-12 Start Llc One-hand locking and releasing handheld medical instrument
US20090149871A9 (en) 2002-11-01 2009-06-11 Jonathan Kagan Devices and methods for treating morbid obesity
US7090690B2 (en) 2002-11-19 2006-08-15 Arthrocare Corporation Devices and methods for repairing soft tissue
US7340300B2 (en) 2003-04-25 2008-03-04 Medtronic, Inc. Neurostimulation delivery during transurethral prostate treatment
MXPA05012303A (en) 2003-05-16 2006-02-22 Bard Inc C R Single intubation, multi-stitch endoscopic suturing system.
JP4338440B2 (en) 2003-05-22 2009-10-07 Hoya株式会社 Magnetic guidance means guidance system for endoscope
US7320701B2 (en) 2003-06-02 2008-01-22 Linvatec Corporation Push-in suture anchor, insertion tool, and method for inserting a push-in suture anchor
US7179225B2 (en) 2003-08-26 2007-02-20 Shluzas Alan E Access systems and methods for minimally invasive surgery
US7303108B2 (en) 2003-09-29 2007-12-04 Ethicon Endo-Surgery, Inc. Surgical stapling instrument incorporating a multi-stroke firing mechanism with a flexible rack
WO2005053517A1 (en) 2003-12-01 2005-06-16 Olympus Corporation Endoscope system
US20050273138A1 (en) 2003-12-19 2005-12-08 Guided Delivery Systems, Inc. Devices and methods for anchoring tissue
US20050154401A1 (en) 2004-01-08 2005-07-14 Scimed Life Systems, Inc. Suturing device for implantable device
US7066944B2 (en) 2004-03-11 2006-06-27 Laufer Michael D Surgical fastening system
US7255675B2 (en) 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
JP4643328B2 (en) 2004-04-07 2011-03-02 オリンパス株式会社 Medical ligature suturing device
US20050228413A1 (en) * 2004-04-12 2005-10-13 Binmoeller Kenneth F Automated transluminal tissue targeting and anchoring devices and methods
US20060282081A1 (en) 2004-04-16 2006-12-14 Fanton Gary S Apparatus and method for securing tissue to bone with a suture
US8057511B2 (en) * 2004-05-07 2011-11-15 Usgi Medical, Inc. Apparatus and methods for positioning and securing anchors
US7497854B2 (en) 2004-05-07 2009-03-03 Ethicon Endo-Surgery, Inc. Method and instrument for effecting anastomosis of respective tissues defining two body lumens
WO2005112786A2 (en) 2004-05-14 2005-12-01 Ethicon Endo-Surgery, Inc. T-type suture anchoring devices and methods of using same
US7334822B1 (en) 2004-05-20 2008-02-26 Hines Jr Robert S Bimini twist knot tying device
US7112186B2 (en) 2004-05-26 2006-09-26 Shah Tilak M Gastro-occlusive device
US7232448B2 (en) 2004-06-17 2007-06-19 Ethicon, Inc. - Usa Minimally invasive stitching device
US7322974B2 (en) 2004-08-10 2008-01-29 Medtronic, Inc. TUNA device with integrated saline reservoir
US7261710B2 (en) 2004-10-13 2007-08-28 Medtronic, Inc. Transurethral needle ablation system
US20060089646A1 (en) 2004-10-26 2006-04-27 Bonutti Peter M Devices and methods for stabilizing tissue and implants
US9463012B2 (en) 2004-10-26 2016-10-11 P Tech, Llc Apparatus for guiding and positioning an implant
US7608108B2 (en) 2005-04-29 2009-10-27 Jmea Corporation Tissue repair system
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US8157815B2 (en) * 2005-05-20 2012-04-17 Neotract, Inc. Integrated handle assembly for anchor delivery system
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
US7588583B2 (en) 2005-09-14 2009-09-15 Rhaphis Medical, Inc. Suturing device, system and method
US20080065120A1 (en) 2005-10-31 2008-03-13 Zannis Anthony D Surgical instrument, kit and method for creating mattress-type stitches
US7850712B2 (en) 2005-11-15 2010-12-14 Ethicon Endo-Surgery, Inc. Self-shielding suture anchor
JP2009530067A (en) 2006-03-22 2009-08-27 シーツーエム メディカル インコーポレーティッド Suture threading device and method of using the same
US7862582B2 (en) * 2006-05-02 2011-01-04 Ethicon Endo-Surgery, Inc. Suture management
WO2007137226A2 (en) 2006-05-19 2007-11-29 Ams Research Corporation Method and articles for treatment of stress urinary incontinence
US8870916B2 (en) 2006-07-07 2014-10-28 USGI Medical, Inc Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use
US9788825B2 (en) 2006-08-04 2017-10-17 Depuy Mitek, Llc Suture anchor with relief mechanism
US9750492B2 (en) 2006-08-04 2017-09-05 Depuy Mitek, Llc Suture anchor system with tension relief mechanism
US20080058710A1 (en) 2006-08-15 2008-03-06 Wilk Peter J Surgical kit, closure device, and associated method
AU2007303137B2 (en) 2006-10-03 2014-04-10 Sinclair Pharmaceuticals Limited Minimally invasive tissue support
US7674275B2 (en) 2006-10-05 2010-03-09 Ethicon Endo-Surgery, Inc. Suture anchor
US8702729B2 (en) 2006-10-13 2014-04-22 Boston Scientific Scimed, Inc. Placing multiple sutures
US20080154378A1 (en) 2006-12-22 2008-06-26 Warsaw Orthopedic, Inc. Bone implant having engineered surfaces
US8617185B2 (en) 2007-02-13 2013-12-31 P Tech, Llc. Fixation device
US8128657B2 (en) 2007-02-27 2012-03-06 Olympus Medical Systems Corp. Suture instrument
US7658311B2 (en) 2007-06-22 2010-02-09 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with a geared return mechanism
US8758366B2 (en) * 2007-07-09 2014-06-24 Neotract, Inc. Multi-actuating trigger anchor delivery system
US20100286106A1 (en) 2008-03-10 2010-11-11 Yigal Gat Methods and apparatus for treating the prostate
US20100023026A1 (en) 2008-07-25 2010-01-28 Zeiner Mark S Reloadable laparoscopic fastener deploying device with disposable cartridge for use in a gastric volume reduction procedure
US9833277B2 (en) 2009-04-27 2017-12-05 Nxthera, Inc. Systems and methods for prostate treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5921982A (en) * 1993-07-30 1999-07-13 Lesh; Michael D. Systems and methods for ablating body tissue
US20050251177A1 (en) * 2004-05-07 2005-11-10 Usgi Medical Inc. Apparatus and methods for rapid deployment of tissue anchors

Cited By (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10143461B2 (en) 2005-05-20 2018-12-04 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10265061B2 (en) 2005-05-20 2019-04-23 Neotract, Inc. Latching anchor device
US10105132B2 (en) 2005-05-20 2018-10-23 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11504149B2 (en) 2005-05-20 2022-11-22 Teleflex Life Sciences Limited Median lobe destruction apparatus and method
US10299780B2 (en) 2005-05-20 2019-05-28 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US11471148B2 (en) 2005-05-20 2022-10-18 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10426509B2 (en) 2005-05-20 2019-10-01 Neotract, Inc. Median lobe destruction apparatus and method
US11090036B2 (en) 2005-05-20 2021-08-17 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US10945719B2 (en) 2005-05-20 2021-03-16 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US10492792B2 (en) 2005-05-20 2019-12-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10575844B2 (en) 2005-05-20 2020-03-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9801650B2 (en) 2006-12-22 2017-10-31 The Spectranetics Corporation Tissue separating systems and methods
US9289226B2 (en) 2006-12-22 2016-03-22 The Spectranetics Corporation Retractable separating systems and methods
US10869687B2 (en) 2006-12-22 2020-12-22 Spectranetics Llc Tissue separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US10537354B2 (en) 2006-12-22 2020-01-21 The Spectranetics Corporation Retractable separating systems and methods
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US9808275B2 (en) 2006-12-22 2017-11-07 The Spectranetics Corporation Retractable separating systems and methods
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US11331093B2 (en) 2012-06-29 2022-05-17 Teleflex Life Sciences Limited Flexible system for delivering an anchor
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
US9724122B2 (en) 2012-09-14 2017-08-08 The Spectranetics Corporation Expandable lead jacket
US9949753B2 (en) 2012-09-14 2018-04-24 The Spectranetics Corporation Tissue slitting methods and systems
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
US10531891B2 (en) 2012-09-14 2020-01-14 The Spectranetics Corporation Tissue slitting methods and systems
US11596435B2 (en) 2012-09-14 2023-03-07 Specrtranetics Llc Tissue slitting methods and systems
US9763692B2 (en) 2012-09-14 2017-09-19 The Spectranetics Corporation Tissue slitting methods and systems
US9925371B2 (en) 2013-03-13 2018-03-27 The Spectranetics Corporation Alarm for lead insulation abnormality
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US10265520B2 (en) 2013-03-13 2019-04-23 The Spetranetics Corporation Alarm for lead insulation abnormality
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US10799293B2 (en) 2013-03-13 2020-10-13 The Spectranetics Corporation Laser ablation catheter
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9937005B2 (en) 2013-03-13 2018-04-10 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
US10485613B2 (en) 2013-03-13 2019-11-26 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US11925380B2 (en) 2013-03-14 2024-03-12 Spectranetics Llc Distal end supported tissue slitting apparatus
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10912637B2 (en) 2013-03-14 2021-02-09 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11850140B2 (en) 2013-03-14 2023-12-26 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10524817B2 (en) 2013-03-15 2020-01-07 The Spectranetics Corporation Surgical instrument including an inwardly deflecting cutting tip for removing an implanted object
US10849603B2 (en) 2013-03-15 2020-12-01 Spectranetics Llc Surgical instrument for removing an implanted object
US10219819B2 (en) 2013-03-15 2019-03-05 The Spectranetics Corporation Retractable blade for lead removal device
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9918737B2 (en) 2013-03-15 2018-03-20 The Spectranetics Corporation Medical device for removing an implanted object
US10314615B2 (en) 2013-03-15 2019-06-11 The Spectranetics Corporation Medical device for removing an implanted object
US11925334B2 (en) 2013-03-15 2024-03-12 Spectranetics Llc Surgical instrument for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US10349932B2 (en) 2013-03-15 2019-07-16 Neotract, Inc. Anchor delivery system
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9956399B2 (en) 2013-03-15 2018-05-01 The Spectranetics Corporation Medical device for removing an implanted object
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US10052129B2 (en) 2013-03-15 2018-08-21 The Spectranetics Corporation Medical device for removing an implanted object
US11129608B2 (en) 2013-03-15 2021-09-28 Neotract, Inc. Anchor delivery system
US11160579B2 (en) 2013-03-15 2021-11-02 Spectranetics Llc Multiple configuration surgical cutting device
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
USD806245S1 (en) 2015-02-20 2017-12-26 The Spectranetics Corporation Medical device handle
USD854682S1 (en) 2015-02-20 2019-07-23 The Spectranetics Corporation Medical device handle
USD819204S1 (en) 2015-02-20 2018-05-29 The Spectranetics Corporation Medical device handle
US11672520B2 (en) 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method
US11298115B2 (en) 2020-08-03 2022-04-12 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions
US11801041B2 (en) 2020-08-03 2023-10-31 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions

Also Published As

Publication number Publication date
EP2345373A1 (en) 2011-07-20
CN102112064B (en) 2014-06-18
EP2345374B1 (en) 2020-05-20
WO2010014821A3 (en) 2010-05-20
JP5871284B2 (en) 2016-03-01
JP2011529745A (en) 2011-12-15
US20100030262A1 (en) 2010-02-04
JP5571079B2 (en) 2014-08-13
EP2339970A2 (en) 2011-07-06
EP2339970B1 (en) 2018-11-14
US8216254B2 (en) 2012-07-10
EP2345374A1 (en) 2011-07-20
CN102112064A (en) 2011-06-29
JP2014054556A (en) 2014-03-27
EP2345373B1 (en) 2020-04-29
WO2010014821A2 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
US8216254B2 (en) Anchor delivery system with replaceable cartridge
EP2164427B1 (en) Multi-actuating trigger anchor delivery system
US9320511B2 (en) Multi-actuating trigger anchor delivery system
US8333776B2 (en) Anchor delivery system
US8945152B2 (en) Multi-actuating trigger anchor delivery system
US7909836B2 (en) Multi-actuating trigger anchor delivery system
US20130296889A1 (en) Anchor delivery system
US20070142846A1 (en) Integrated handle assembly for anchor delivery system
US20070049929A1 (en) Apparatus and method for manipulating or retracting tissue and anatomical structure
US20190125334A1 (en) System for delivering an anchor
US20210267579A1 (en) Anchor delivery system

Legal Events

Date Code Title Description
AS Assignment

Owner name: NEOTRACT, INC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CATANESE, JOSEPH, III;LAMSON, THEODORE C;MAKOWER, JOSHUA;AND OTHERS;SIGNING DATES FROM 20091009 TO 20091015;REEL/FRAME:032214/0100

AS Assignment

Owner name: PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.

Free format text: SHORT-FORM PATENT SECURITY AGREEMENT;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:032525/0104

Effective date: 20140324

Owner name: CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.

Free format text: SHORT-FORM PATENT SECURITY AGREEMENT;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:032525/0104

Effective date: 20140324

Owner name: CAPITAL ROYALTY PARTNERS II L.P., TEXAS

Free format text: SHORT-FORM PATENT SECURITY AGREEMENT;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:032525/0104

Effective date: 20140324

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NEOTRACT, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNORS:CAPITAL ROYALTY PARTNERS II L.P.;CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.;PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.;REEL/FRAME:044114/0608

Effective date: 20171002

AS Assignment

Owner name: TELEFLEX LIFE SCIENCES LIMITED, MALTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:058917/0381

Effective date: 20211210